Advertisement

Die chronische lymphatische Leukämie

  • Harald Theml
Part of the Handbuch der Inneren Medizin book series (INNEREN, volume 2 / 6)

Zusammenfassung

Kaum ein Krankheitsbild aus der Gruppe der lymphoretikulären Systemerkrankungen dürfte eine größere Varianzbreite in klinischer Phänomenologie, patho-mechanischer Entwicklung und Prognose haben als die chronische lymphatische Leukämie (CLL). Über kaum eine Zelle dürfte aber auch in den letzten 5 Jahren mehr an grundlegenden neuen Befunden erbracht worden sein als über den krankheitsbestimmenden Lymphozyten der CLL. Diese Vielseitigkeit und Aktualität der chronischen Lymphadenose widerspricht der Bearbeitung durch einen Autor und es muß diesem Kapitel vorangestellt werden, daß sein klinischer Teil ursprünglich von Dr. H.G. Harwerth bearbeitet wurde und sich der unvorhergesehen mit dem Gesamtthema allein konfrontierte Autor neben neueren Übersichten (Begemann, 1970; Hansen, 1973) auf die umfassende Vorarbeit (Harwerth et al., 1963) stützen durfte. Stellenweise berücksichtigte eigene Beobachtungen am Krankengut der I. Medizinischen Abteilung des Städtischen Krankenhauses München-Schwabing werden in Form einer Inaugural-Dissertation von Herrn cand. med. H. Helmbrecht (1976) analysiert.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Ackermann, G.A.: Histochemistry of normal and leukemic lymphocytes. J. Histochem. Cytochem. 7, 318 (1959).Google Scholar
  2. Airo, R., Mihailescu, E., Astaldi, G., Meardi, G.: Skin reactions to phytohemagglutinin. Lancet 1967 I, 889.Google Scholar
  3. Aisenberg, A.C.: Malignant lymphoma. New Engl. J. Med. 288, 883 (1972).CrossRefGoogle Scholar
  4. Aisenberg, A.C., Bloch, K.J.: Immunoglobulins on the surface of neoplastic lymphocytes. New. Engl. J. Med. 287, 272 (1972).PubMedCrossRefGoogle Scholar
  5. Aisenberg, A.C., Bloch, K.J., Long, J.C., Colvin, R.B.: Reaction of normal human lymphocytes and chronic lymphocytic leukemia cells with an antithymocyte antiserum. Blood 41, 417 (1973).PubMedGoogle Scholar
  6. Aiuti, F., Lacava, V., Fiorilli, M., Ciarla, M.V.: Lymphocyte surface markers in lymphoproliferative disorders. Acta haemat. (Basel) 50, 275 (1973).CrossRefGoogle Scholar
  7. Albright, E.C., Middleton, W.S.: The uptake of radioactive iodine by the thyroid gland of leukemic patients. Blood 5, 764 (1950).PubMedGoogle Scholar
  8. Altmann, H.W.: Zur Kenntnis der Kerngestalt, des Cytozentrums und der Mitosestörung in Sternber’schen Riesenzellen. Klin. Wschr. 42, 1117 (1964).PubMedCrossRefGoogle Scholar
  9. Amos, D.B., v. Rood, J.J.: Histocompatibility Testing. Kopenhagen: Munksgaard 1965.Google Scholar
  10. Andersen, V., Karle, H., Dige-Petersen, H.: Haemolysis in patients with chronic lymphocytic leukaemia during extracorporeal irradiation of the blood. Scand. J., Haemat. 7, 222 (1970).CrossRefGoogle Scholar
  11. Anderson, V., Sorensen, S.F., Killmann, S.A.: Tratiment de la leucemie lymphoide chronique par l’irradiation extracorporelle du sang. Nouv. Rev. franç. Hémat. 8, 709 (1968).Google Scholar
  12. Ardaillou, R., Slama, R.: Les complications rénales des hémopathies malignes. Path, et Biol. 9, 1049 (1961).Google Scholar
  13. Asamer, H.: Zur immunzytologischen Charakterisierung immunkompetenter Lymphozyten. Wien. klin. Wschr. 84, 401 (1972).Google Scholar
  14. Askanazy, M.: Allgemeine Morphologie und Biologie des normalen Knochenmarks. In Handbuch der speziellen pathologischen Anatomie und Histologie (F. Henke, O. Lubarsch, Hrsg.), Bd. 1, S. 775–812. Berlin: Springer 1927.Google Scholar
  15. Astaldi, G., Airo, R., Costa, G., Duarte, N.: Milzbestrahlung und immunologische Antwort peripherer Lymphozyten von chronisch-lymphatischen Leukämien. Blut 13, 100 (1966).PubMedCrossRefGoogle Scholar
  16. Astaldi, G., Verga, L.: The glycogen content of the cells of lymphatic leukaemia. Acta haemat. (Basel) 17, 129 (1957).CrossRefGoogle Scholar
  17. Aström, K.E., Mancall, E.L., Richardson, E.P.: Progressive multifocal leuko-encephalopathy. A hitherto unrecognized complication of chronic lymphatic leukaemia and Hodgkin’s disease. Brain 81, 93 (1958).PubMedCrossRefGoogle Scholar
  18. Augener, W., Cohnen, G., Brittinger, G.: Binding of aggregated IgG by lymphocytes in chronic lymphocytic leukemia. Biomedicine 21, 6 (1974).PubMedGoogle Scholar
  19. Auriol, M., Lasneret, J.: Leukemia and lung. Bull. Ass. franç. Cancer 46, 274 (1959).PubMedGoogle Scholar
  20. Awwad, H.K., Badeeb, A.O., Massoud, G.E., Salah, M.: The effect of splenic X-irradiation on the ferrokinetics of chronic leukemia with a clinical study. Blood 29, 242 (1967).PubMedGoogle Scholar
  21. Azar, H.A., Hill, W.T., Osserman, E.F.: Malignant lymphoma and lymphatic leukemia associated with myeloma-type serum proteins. Amer. J. Med. 23, 239 (1957).PubMedCrossRefGoogle Scholar
  22. Barnes, B.A., Brownell, G.L., Flax, M.H.: Irradiation of the blood. Method for reducing lymphocytes in blood and spleen. Science 145, 1188 (1964).PubMedCrossRefGoogle Scholar
  23. Barnes, G.R., jr., Yannet, H., Lieberman, R.: A clinical study of an institutional outbreak of acute infectious lymphocytosis. Amer. J. med. Sci. 218, 646 (1949).PubMedCrossRefGoogle Scholar
  24. Barbieri, A.D.: Sintesi e screening di peptidi a azione alchilante e antimetabolica. Atti Acad. med. lombarda 21, 2377 (1966).Google Scholar
  25. Bartfeld, H.: Ann. intern. Med. 52, 1059 (1960). Zit. nach Harwerth et al. (1963).Google Scholar
  26. Barton, R.L., O’Leary, P.A.: Herpes zoster generalisatus associated with chronic lymphatic leukemia. Arch. Derm. 51, 263 (1945).Google Scholar
  27. Beck, W.S.: Occurrence and control of phosphogluconate oxydation pathway. J. biol. Chem. 232, 251 (1958).PubMedGoogle Scholar
  28. Beck, W.S., Valentine, W.N.: Aerobic carbohydrat metabolism of leukocytes. Cancer Res. 12, 818 (1952).PubMedGoogle Scholar
  29. Beck, W.S., Valentine, W.N.: Biochemical studies on leukocytes. II. Phosphatase activity in chronic lymphatic leucemia, acute leucemia and miscellaneous hematologic conditions. J. Lab. clin. Med. 38, 245(1951).PubMedGoogle Scholar
  30. Beek, C.H.: Skin manifestations associated with lymphatic-leucemia. Dermatologica 96, 350 (1948).PubMedCrossRefGoogle Scholar
  31. Begemann, H.: Klinische und experimentelle Beobachtungen am immunisierten Lymphknoten. Freiburg: H.F. Schulz 1953.Google Scholar
  32. Begemann, H.: Clinical experience with Actinomycin C. Ann. N.Y. Acad. Sci. 89, 454 (1960).PubMedCrossRefGoogle Scholar
  33. Begemann, H.: Infektiöse Lymphocytose und verwandte Zustände. In: Hdb. der ges. Haematologie (L. Heilmeyer, A. Hittmair, Hrsg.), Bd. IV. München: Urban & Schwarzenberg 1963.Google Scholar
  34. Begemann, H.: Die Splenektomie bei Lymphogranulomatose-Kranken. Med. Klin. 70, 591 (1975).PubMedGoogle Scholar
  35. Begemann, H., Czempiel, H., Fink, U., Pichlmaier, H., Rastetter, H., Trepel, F., Wernekke, G.: Die Therapie der chronischen Lymphadenose. In: Chemo- und Immunotherapie der Leukosen und malignen Lymphome. Internationale Arbeitstagung, Wien 1969, S. 242. Wien: Bohmann 1969.Google Scholar
  36. Begemann, H., Loose, W., Trepel, F., Pichlmaier, H.: Behandlung der chronischen lymphatischen Leukämie durch extrakorporale Bestrahlung. Klin. Wschr. 46, 673 (1968).PubMedCrossRefGoogle Scholar
  37. Begemann, H., Rastetter, H., Fink, U.: Zur Klassifizierung der Lymphozyten. Med. Klin. 58, 706 (1963).PubMedGoogle Scholar
  38. Begemann, H., Rastetter, J., Kaboth, W.: Klinische Hämatologie. Stuttgart: Thieme 1970.Google Scholar
  39. Begemann, H., Theml, H., Fink, U.: Die Therapie der chronischen lymphatischen Leukämie. In: Leukämien und maligne Lymphome (A. Stacher, Hrsg.), S. 293. München-Berlin-Wien: Urban u. Schwarzenberg 1973.Google Scholar
  40. Begemann, H., Theml, H., Winnewisser, M.: Beitrag zu: Immunologie in Pathogenese, Diagnostik und Therapie von Tumoren. Verh. dtsch. Ges. inn. Med. 78, 112 (1973).Google Scholar
  41. Begemann, H., Zawadzky, E.v.: Hautfenster-Untersuchungen bei verschiedenen Blutkrankheiten. Med. Klin. 62, 90 (1967).PubMedGoogle Scholar
  42. Beickert, A.: Die hämolytische Verlaufsform der chronischen lymphatischen Leukämie. Münch. med. Wschr. 101, 2067 (1959).PubMedGoogle Scholar
  43. Bennett, J.H.: Case of hypertrophy of the spleen and liver, in which death took place from suppuration of the blood. Edinburgh med. J. 64, 413 (1845).Google Scholar
  44. Bennett, J.H.: Leucocythaemia, or White Cell Blood, in Relation to the Physiology and Pathology of the Lymphatic Glandular System. Edinburgh: Sutherland & Knox 1852.Google Scholar
  45. Bennett, M.H., Farrer-Brown, G., Henry, K., Jelliffe, A.M.: Classification of non-Hodgkin’s lymphomas. Lancet 1974 II, 405.CrossRefGoogle Scholar
  46. Benninghoff, D.L., Girardet, R.E., Porteous, D.D.: Thoracic-duct and blood lymphocytes in cancer. Lancet 1973 II, 264.CrossRefGoogle Scholar
  47. Bentwich, Z., Douglas, S.D., Siegal, F.P., Kunkel, H.G.: Human lymphocyte-sheep erythrocyte rosette formation. Some characteristics of the interaction Clin. Immunol. Immunopath. 1, 511 (1973).CrossRefGoogle Scholar
  48. Bentwich, Z., Kunkel, H.G.: Specific properties of human B and T lymphocytes and alteration in disease. Transplant. Rev. 16, 29 (1973 b).PubMedGoogle Scholar
  49. Bentwich, Z., Weiss, D.W., Sulitzeanu, D., Kedar, E., Izak, G., Cohen, I., Eyal, O.: Antigenic changes on the surface of lymphocytes from patients with chronic lymphocytic leukemia. Cancer Res. 32, 1375 (1972).PubMedGoogle Scholar
  50. Berg, J.W.: The incidence of multiple primary cancers. I. Development of further cancers in patients with lymphomas, leukemias, and myeloma. J. nat. Cancer Inst. 38, 741 (1967).PubMedGoogle Scholar
  51. Berke, G., Amos, D.B.: Mechanism of lymphocyte-mediated cytolysis. The LMC cycle and its role in transplatation immunity. Transplant. Rev. 17, 71 (1973).PubMedGoogle Scholar
  52. Berlin, R.: Red cell survival studies in normal and leukemic subjects. Acta med. scand, Suppl. 252, 57 (1951).Google Scholar
  53. Bernard, C., Geraldes, A., Boiron, M.: Effects of phytohaemagglutinin on blood cultures of chronic lymphocytic leucaemia. Lancet 1964 I, 667.CrossRefGoogle Scholar
  54. Bethel, F.H.: Lymphogenous (lymphatic) leukemia. J. Amer. med. Ass. 118, 95 (1942).Google Scholar
  55. Bethell, F.H.: Leukemia: the relative incidence of its various forms, and their response to radiation therapy. Ann. intern. Med. 18, 757 (1943).Google Scholar
  56. Bichel, J.: Mediastinal tumors in leukosis. Acta radiol. (Stockh.) 28, 81 (1947).CrossRefGoogle Scholar
  57. Biermann, H.R.: The leukemias — proliferative or accumulative? Blood 30, 238 (1967).Google Scholar
  58. Bierman, H.R., Perkins, E.K., Ortega, P.: Amer. Heart J. 22, 417 (1952). Zit. nach Harwerth et al., 1963.Google Scholar
  59. Binet, J.L., Logeais, Y., Villeneuve, B., Mathey, J., Bernard, J.: Examen de la lymphe au cours de la leucemie lymphoide chronique. Nouv. Rev. franç. Hémat. 6, 568 (1966).PubMedGoogle Scholar
  60. Bizzozero, O.J., Johnson, K.G., Ciocco, A.: Radiation related leukemia in Hiroshima and Nagasaki. 1946–1964. New Engl. J. Med. 274, 1095 (1966).PubMedCrossRefGoogle Scholar
  61. Blendis, L.M., Clarke, M.B., Williams, R.: Effects of splenectomy on the haemodilutional anaemia of splenomegaly. Lancet 1969 I, 795.CrossRefGoogle Scholar
  62. Block, J.B., Haynes, H.A., Thompson, W.L., Neiman, P.E.: Delayed hypersensitivity in chronic lymphocytic leukemia. J. nat. Cancer Inst. 42, 973 (1969).PubMedGoogle Scholar
  63. Bloomfield, C.D., Goldman, A., Dick, F., Brunning, R.D., Kennedy, B.J.: Multivariate analysis of prognostic factors in the non-Hodgkin’s malignant lymphomas. Cancer (Philad.) 33, 870 (1974).CrossRefGoogle Scholar
  64. Bluefarb, S.M.: Leukemia Cutis. Springfield/Ill. Thomas 1960.Google Scholar
  65. Bock, H.E.: Die Durchführung von Zytostatikakuren. Wien. klin. Wschr. 78, 541 (1966).Google Scholar
  66. Bock, H.E., Gross, R., Lambers, K., Wulf G.: Leukämie und Leber. Medizinische 1959, 1325.Google Scholar
  67. Boggs, D.R.: The cellular composition of the inflammatory exsudates in human leukemias. Blood 15, 466 (1960).PubMedGoogle Scholar
  68. Boggs, D.R., Sofferman S.A., Wintrobe, M.M., Cartwright, G.E.: Factors influencing the duration of survival of patients with chronic lymphocytic leucemia. Amer. J. Med. 40, 243 (1966).PubMedCrossRefGoogle Scholar
  69. Bonadonna, G., Monfardini S., Guindani, A.: Daunomycin treatment in chronic lymphoprolife-rative disorders. Tumori 54, 465 (1968).PubMedGoogle Scholar
  70. Booth, K., Hancock, P.E.T.: A study of the total and differential leukocyte counts and haemoglobin levels in a group of normal adults over a period of two years. Brit. J. Haemat. 7, 9 (1961).CrossRefGoogle Scholar
  71. Borella, L., Sen, L.: T cell surface markers on lymphoblasts from acute lymphocytic leukemia. J. Immunol. III, 1257 (1973).Google Scholar
  72. Borne v.d., A.E.G.K., Engelfriet, C.P., Beckers, D., v.d. Kort-Henkes, G., v.d. Giessen, M., v. Loghem, J.J.: Autoimmune haemolytic anaemias. II. Warm hämolysins-serological and immunochemical investigations and 51Cr studies. Clin. exp. Immunol. 4, 333 (1969).Google Scholar
  73. Bottomley, R.H., Locke, S.J., Ingram, H.C.: Lactic dehydrogenase of human chronic lymphocytic leukemic leukocytes. Blood 27, 85 (1966).PubMedGoogle Scholar
  74. Bouroncle, B.A., Clausen, K.P., Aschenbrand, O.F.: Studies of the delayed response of phytohaemagglutinin (PHA) stimulated lymphocytes in 25 chronic lymphatic leukemia patients before and during therapy. Blood 34, 166 (1969).PubMedGoogle Scholar
  75. Boutis, L., Obrecht, P., Musshoff, K., Jochmann, P.: Zur Prognose der chronischen lymphatischen Leukämie. Dtsch. med. Wschr. 44, 2111 (1968).CrossRefGoogle Scholar
  76. Brass, B., Theml, H., Backmund, H., Lob, G., Seifert, J., Brendel, W., Spelsberg, F.: Drainage des Ductus thoracicus beim Menschen. Med. Klin. 68, 1399 (1973).PubMedGoogle Scholar
  77. Braunsteiner, H.: Immunzytologische Untersuchungen über das Verteilungsmuster von Ig-Determi-nanten bei Myelompatienten. Hinweise für eine klassenspezifische Restriktion auf B-Zellebene. Acta haemat. (Basel) 49, 80 (1973).CrossRefGoogle Scholar
  78. Bremer, K., Fliedner, T.M.: Neuere Gesichtspunkte zur Kinetik von Lymphozytenpopulationen. In: Leukämien und maligne Lymphome (Ed. Stacher, A.), p. 202–211. München-Berlin-Wien: Urban u. Schwarzenberg 1973.Google Scholar
  79. Bremer, K., Fliedner, T.M., Schick, P.: Kinetic differences of autotransfused 3H-cytidine labeled blood lymphocytes in leukemic and non-leukemic lymphoma patients. Europ. J. Cancer 9, 113 (1973).CrossRefGoogle Scholar
  80. Bremer, K., Schick, P., Wack, O., Theml, H., Brass, B., Heimpel, H.: Rezirkulation von Lymphozyten bei Patienten mit malignen lymphatischen Systemerkrankungen. Blut 24, 215 (1972).PubMedGoogle Scholar
  81. Bremer, K., Schreml, W., Flad, H.D.: Anreicherung normaler Lymphozyten in der Lymphe von Patienten mit chronischer lymphatischer Leukämie. Verh. Dtsch. Ges. inn. Med. 79, 545 (1973).PubMedGoogle Scholar
  82. Brent, L., Davies, A.J.S.: Die Regulation des lymphatischen Systems. In: Lymphozyt und klinische Immunologie (H. Theml, H. Begemann, Hrsg.). Berlin-Heidelberg-New York: Springer 1975.Google Scholar
  83. Brittinger, G., König, E., Aberle, H.G., Zimmerschitt, E.: Lysosomale Enzyme in Blutlymphozy-ten von Gesunden und Patienten mit chronischer Lymphadenose bei kurzdauernder unspezifischer Stimulation in vitro. Schweiz, med. Wschr. 100, 341 (1970).Google Scholar
  84. Brittinger, G., König, E., Cohnen, G., Aberle, H.G.: Lysosomale Enzyme in Lymphozyten. I. Acta haemat. (Basel) 44, 205 (1970).CrossRefGoogle Scholar
  85. Brock, N., Hohorst, H.J.: Über die Aktivierung von Cyclophosphamid in vivo et in vitro. Arzneimittel-Forsch. 13, 1021 (1963).Google Scholar
  86. Brody, J.I., Beizer, L.H.: Alteration of blood group antigens in leukemic lymphocytes. J. clin. Invest. 44, 1582(1965).PubMedCrossRefGoogle Scholar
  87. Brody, J.I., Beizer, L.H.: Immunologic incompetence of the neoplastic lymphocyte in chronic lymphocytic leukemia. Ann. intern. Med. 64, 1237 (1966).PubMedGoogle Scholar
  88. Brody, J.I., Oski, F.A., Singer, D.E.: Inpaired pentose phosphate shunt and decreased glycolytic activity in lymphocytes of chronic lymphocytic leukemia: Metabolic pathway? Blood 34, 421 (1969).PubMedGoogle Scholar
  89. Broome, J.D., Zucker-Franklin, D., Weiner, M.S., Bianco, C., Nussenzweig, V.: Leukemic cells with membrane properties of thymus-derived (T) lymphocytes in a case of Sezary’s syndrome. Morphologic and immunologic studies. Clin. Immunol. Immunopath. 1, 319 (1973).CrossRefGoogle Scholar
  90. Brouet, J.-C., Preudhomme, J.-L., Seligman, M., Bernard, J.: Blast cells with monoclonal surface immunglobulin in two cases of acute blast crisis supervening on chronic lymphocytic leukaemia. Brit. med. J. 1973 IV, 23.CrossRefGoogle Scholar
  91. Brown, R.C., Campbell, D.C., Thompson, J.H.: Increased fibrinolysin with malignant disease. Arch, intern. Med. 109, 201 (1962).Google Scholar
  92. Bruce, W.R., Meeker, B.E., Valeriote, F.A.: Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J. nat. Cancer Inst. 37, 233 (1966).PubMedGoogle Scholar
  93. Brunner, K., Keiser, G., Martz, G.: Die Corticosteroidtherapie der chronischen lymphatischen Leukaemie. Dtsch. med. Wschr. 88, 1128 (1963).PubMedCrossRefGoogle Scholar
  94. Brus, J., Lewis, S.M.: The haptoglobin content of serum in haemolytic anaemia. Brit. J. Haemat. 5, 348 (1959).PubMedCrossRefGoogle Scholar
  95. Burkhardt, R.: Farbatlas der klinischen Histopathologic von Knochenmark und Knochen. Berlin-Heidelberg-New York: Springer 1970.Google Scholar
  96. Burmingham, R.A., Restrepo, A., Pugh, R.P., Brown, E.B., Schzossman, S.F., Khuri, P.D., Lessner, H.E., Harrington, W.J.: Weekly high dosage glucocorticosteroid treatment of lymphocytic leukemias and lymphomas. New Engl. J. Med. 270, 1160 (1964).CrossRefGoogle Scholar
  97. Carneskog, O.: Några synspunkter på ett leukämimaterial. Nord. Med. 55, 477 (1956).Google Scholar
  98. Cardozo, P.L.: Chronische lymphatische Riederzellenleukämie. Schweiz, med. Wschr. 94, 1350 (1964).Google Scholar
  99. Catovsky, D., Galetto, J., Okos, A., Galton, D.A.G., Wiltshaw, E., Stathopoulos, G.: Prolymphocytic leukaemia of B and T cell type. Lancet 1973 II, 232.CrossRefGoogle Scholar
  100. Catovsky, D., Galton, D.A.G.: Myelomonocytic leukemia supervening on chronic lymphocytic leukemia. Lancet 1971 I, 478.CrossRefGoogle Scholar
  101. Catovsky, D., Holt, P.J.L.: T or B lymphocytes in chronic lymphocytic leukaemia. Lancet 1971 II, 976.CrossRefGoogle Scholar
  102. Catovsky, D., Holt, P.J.L., Galton, D.A.G.: Lymphocyte transformation in immunoproliferative disorders. Brit. J. Cancer 26, 154 (1972).PubMedCrossRefGoogle Scholar
  103. Catovsky, D., Miliani, E., Okos, A., Galton, I.A.G.: Clinical significance of T-cells in chronic lymphocytic leukemia. Lancet 1974 II, 751.CrossRefGoogle Scholar
  104. Christensen, E., Hansen, L.K., Kristensen, J.K., Videbaek, A.: Splenectomy in haematology. Scand. J. Haemat. 7, 247 (1970).PubMedCrossRefGoogle Scholar
  105. Claman, H.D., Mosier, B.E.: Cell-interactions in antibody-production. Progr. Allergy 16, 40 (1972).CrossRefGoogle Scholar
  106. Chiappa, S., Bonadonna, G., Uslenghi, C., Marano, P., Molinari, R.: The role of endolymphytic radiotherapy in the treatment of chronic lymphatic leukaemia. Brit. J. Cancer 20, 480 (1966).PubMedCrossRefGoogle Scholar
  107. Chodos, R.B., Ross, J.F.: The use of radioactive phosphorus in the therapy of leukemia, polycythemia vera and lymphomas. A report of 10 years’ experience. Ann. intern. Med. 48, 956 (1958).PubMedGoogle Scholar
  108. Christensen, B.E.: Effects of an enlarged splenic erythrocyte pool in chronic lymphatic leukaemia. Scand. J. Haemat. 8, 92 (1971).CrossRefGoogle Scholar
  109. Christensen, E., Hansen, L.K., Kristensen, J.K., Videbaek, A.A.: Splenectomy in Haematology. Scand. J. Haemat. 7, 247 (1970).PubMedCrossRefGoogle Scholar
  110. Christensen, C., Ottesen, J.: The age of leukocytes in the blood stream of patients with chronic lymphocytic leukemia. Acta haemat. (Basel) 13, 289 (1955).CrossRefGoogle Scholar
  111. Clark, C., Rydell, R.E., Kaplan, M.E.: Frequent association of IgM with crystalline inclusions in chronic lymphatic leukemic lymphocytes. New Engl. J. Med. 289, 113 (1973).PubMedCrossRefGoogle Scholar
  112. Clarkson, B., Ota, K., Ohkita, T., O’Connor, A.: Kinetics of proliferation of cancer cells in neoplastic effusions in man. Cancer (Philad.) 18, 1189 (1965).CrossRefGoogle Scholar
  113. Clarksaon, B., Strife, A., Fried, J., Sakai, Y., Ota, K., Okita, T., Masuda, R.: Studies of cellular proliferation in human leukemia. IV. Behavior of normal hematopoietic cells in 3 adults with acute leukemia given continuous infusions of 3H-thymidine for 8 or 10 days. Cancer (Philad.) 26, 1 (1970).CrossRefGoogle Scholar
  114. Clausen, K.P., Bouroncle, B.A.: The ultrastructure of phytohaemagglutinin (PHA) stimulated lymphocytes of chronic lymphatic leukemia. Blood 34, 179 (1969).PubMedGoogle Scholar
  115. Clemmesen, J.: Statistical Studies in Malignant Neoplasms, Vol. II. Kopenhagen: Munksgaard 1964.Google Scholar
  116. Coco, F., Merritt, J.A.: Cyclophosphamide-Induced changes in circulating lymphocyte kinetics in chronic lymphocytic leukemia. Cancer (Philad.) 25, 721 (1970).CrossRefGoogle Scholar
  117. Cohen, J.J., Claman, H.N.: Thymus-marrow immunocompetence. Hydrocortisone resistant cells and processes in the hemolytic antibody response of mice. J. exp. Med. 133, 1026 (1971).PubMedCrossRefGoogle Scholar
  118. Cohnen, G.: Funktion und Oberflächenmarker menschlicher T- und B-Lymphozyten. Dtsch. med. Wschr. 99, 2241 (1974a).PubMedCrossRefGoogle Scholar
  119. Cohnen, G.: Klinisch-diagnostische Bedeutung der Oberflächenmarker menschlicher T- und B-Lym-phozyten. Dtsch. med. Wschr. 99, 2302 (1974 b).PubMedCrossRefGoogle Scholar
  120. Cohnen, G., Douglas, S.D., König, E., Bremer, K., Brittinger, G.: Crystalloid intracytoplasmic inclusions in lymphocytes of a patient with chronic lymphocytic leucemia. Mount Sinai J. Med. 40, 249 (1973).Google Scholar
  121. Cohnen, G., Douglas, D., König, E., Brittinger, G.: Pokeweed mitogen response of lymphocytes in chronic lymphocytic leucemia: A fine structural study. Blood 42, 591 (1973).PubMedGoogle Scholar
  122. Cone, L., Uhr J.H.: Immunological deficiency disorders associated with chronic lymphocytic leukemia and multiple myeloma. J. clin. Invest. 43, 2241 (1964).PubMedCrossRefGoogle Scholar
  123. Cook, J.C., Romano, W.: Chronic lymphocytic leukemia and radiation therapy. Amer. J. Roentgenol. 88, 892 (1962).PubMedGoogle Scholar
  124. Cooper, M.D., Lawton, A.R., Kincade, P.W.: A two-stage model for development of antibodyproducing cells. Clin. exp. Immunol. 11, 143 (1972).PubMedGoogle Scholar
  125. Cornes, J.S., Jones, T.G.: Leukaemic lesions of the gastrointestinal tract. J. clin. Path. 15, 305 (1962).PubMedCrossRefGoogle Scholar
  126. Correa, P., O’Conor, G.T.: Geographic pathology of lymphoreticular tumors. J. nat. Cancer Inst. 50, 1609 (1973).PubMedGoogle Scholar
  127. Cottier, H., Cronkite, E.P., Jansen, C.R., Rai, K.R., Singer, S., Sipe, C.R.: Studies on lymphocytes. III. Effect of extracorporal irradiation of the circulating blood upon the lymphoreticular organs of the calf. Blood 24, 241 (1964).PubMedGoogle Scholar
  128. Cottier, H., Hess, M.W., Schädeli, J., Bürki, H.: Lymphozytenformen: Herkunft und Entwicklungsmöglichkeiten. Verh. dtsch. Ges. inn. Med. 79, 99 (1973).PubMedGoogle Scholar
  129. Cottier, H., Ruchi, C., Sordat, B., Cronkite, E.P.: Irradiation extra-corporelle du sang circulant: moyens d-etude des circulation lymphocytaires chez le veau. Nouv. Rev. franç. Hémat. 8, 679 (1968).PubMedGoogle Scholar
  130. Court-Brown, W.M., Buckton, K., McLean, A.S.: Quantitative studies of chromosome aberration in man following acute and chronic exposure to X-rays and gamma rays. Lancet 1965 I, 1239.CrossRefGoogle Scholar
  131. Court Brown, W.M., Doll, R.: Adult leukaemia. Trends in mortality in relation to aetiology. Brit. med. J. 1959 I, 1063.CrossRefGoogle Scholar
  132. Court Brown, W.M., Doll, R., Hill, I.D.: Leukemia in Britain and Scandinavia. Path, et Microbiol. (Basel) 27, 644 (1964).Google Scholar
  133. Craigie, D.: Case of disease of spleen, in which death took place in consequence of the presence of purulent matter in the blood. Edinburgh med. J. 64, 400 (1845).Google Scholar
  134. Craver, L.F., Haagensen, C.D.: Note on occurrence of herpes zoster in Hodgkin’s disease, lymphosarcoma, and the leukemias. Amer. J. Cancer 16, 502 (1932).Google Scholar
  135. Craver, L.F., Copeland, M.M.: Changes of the vones in the leukemias. Arch. Surg. 30, 639 (1935).Google Scholar
  136. Creyssel, R., Morel, P., Pellet, M., Medard, J., Revol, L., Croizat, P.: Deficit en gammaglobulines et complications infectieuses des leucemies lymphoides chroniques. Sang 29, 383 (1958).PubMedGoogle Scholar
  137. Croizat, P., Revol, L., Rendu, G.: Etude statistique des lymphoses. Sang 26, 341 (1955).PubMedGoogle Scholar
  138. Cronkite, E.P.: Extracorporeal irradiation of the blood in the study of lymphocyte proliferation and function. In: Grundlagenforschung in ihrer Bedeutung für die klinische Medizin (W. Keiderlin, Hrsg.), S. 221. Stuttgart 1965.Google Scholar
  139. Cronkite, E.P.: Extracorporeal irradiation of blood in treatment of chronic lymphocytic leukemia. In: Rec. Res. Cancer Res. (E. Ultmann, Ed.), p. 67. Berlin-Heidelberg-New York: Springer 1971.Google Scholar
  140. Cronkite, E.P., Bond, V.P., Fliedner, T.M., Killmann, S.A.: The use of tritiated thymidine in the study of hemopoietic cellproliferation. In: Ciba Foundation Symposium on Hemopoieses (G.E.W. Wolstenholme, M. O’Connor, Eds.). London: Churchill 1960.Google Scholar
  141. Cronkite, E.P., Fliedner, T.M., Bond, V.P., Rubini, J.R., Brecher, G., Quastler, H.: Dynamies of haemopoetic proliferation in man and mice studied by 3H-thymidine incorporation into DNA. Proc. 2nd. Internat. Conference on peaceful uses of atomic energy, vol. 25, p. 190. London: H.M.S.O. 1958.Google Scholar
  142. Cronkite, E.P., Jansen, C.R., Mathe, G., Adamik, E.A., Sipe, C.R.: The induction of a prolonged lymphopenia by extracorporeal irradiation of the blood. Radiat. Res. 16, 586 (1961).Google Scholar
  143. Cronkite, E.P., Jansen, C.R., Mather, G.C., Nielsen, N., Usenik, E.A., Adamik, E.R., Sipe, C.R.: Studies of lymphocytes. I. Lymphopenia produced by prolonged extracorporeal irradiation of the circulating blood. Blood 20, 203 (1962).PubMedGoogle Scholar
  144. Crossen, P.E., Mellor, J.E.L., Finley, A.G., Ravich, R.B.M., Vincent, P.C., Gunz, F.W.: The Sezary syndrome: cytogenic studies and identification of the Sezary cell as an abnormal lymphocyte. Amer. J. Med. 50, 24 (1971).PubMedCrossRefGoogle Scholar
  145. Curtis, J.E., Hersh, E.M., Freireich, E.J.: Leukapheresis therapy of chronic lymphocytic leukemia. Blood 39, 163 (1972).PubMedGoogle Scholar
  146. Dacie, J.V.: The Haemolytic Anaemias. 2nd Ed. Vol. 3. London: Churchill 1967.Google Scholar
  147. Dameshek, W.: Chronic lymphocytic leukemia-an accumulative disease of immunologically incompetent lymphocytes. Blood 29, 566 (1967).PubMedGoogle Scholar
  148. Dameshek, W., Gunz, F.: Leukemia. 2nd Ed. New York: Grune & Stratton 1964.Google Scholar
  149. Dameshek, W., Schwartz, R.S.: Leukemia and auto-immunization some possible relationships. Blood 14, 1151 (1959).PubMedGoogle Scholar
  150. Dameshek, W., Schwartz, R.S., Oliner, H.: Current concepts of auto-immunization. Blood 17, 775 (1961).Google Scholar
  151. David, J.R.: Lymphocyte mediators and cellular hypersensitivity. New Engl. J. Med. 288, 143 (1973).PubMedCrossRefGoogle Scholar
  152. Davies, A.J.S.: Thymus and cellular basis of immunity. Transplant. Rev. 1, 43 (1969).PubMedGoogle Scholar
  153. Davies, A.J.S., Leuchars, E., Wallis, V., Koller, P.C.: The mitotic response of thymus-derived cells to antigenic stimulus. Transplantat. Rev. 4, 438 (1966).CrossRefGoogle Scholar
  154. Davis, S.: Hypothesis: Differentiation of the human lymphoid system based on cell surface markers. Blood 45, 871 (1975).PubMedGoogle Scholar
  155. Dawson, D.B.H.: Changes in the fundus in diseases of the blood. In: Modern Trends in Blood Diseases (J.F. Wilkinson, Ed.), p. 212. London: Butterworth 1955.Google Scholar
  156. Degos, L., Drolet, Y., Dausset, J.: HL-A antigens in chronic myeloid leukemia (CML) and chronic lymphocytic leukemia (CLL). (International Symposium on Relationships between Tumour Antigens and Histocompatibility Systems.) Transplant. Proc. 3, 1309 (1971).Google Scholar
  157. Delmas-Marsalet, Y., Hors, J., Colombani, J., Dausset, J.: Study of HL-A genotypes in a case of familial chronic lymphocytic leukaemia (CLL). Tissue Antigens 4, 441 (1974).CrossRefGoogle Scholar
  158. Demmler, K., Vykoupil, K.F., Georgii, A.: Über die Beziehungen von leukämischem Blut und leukotischer Organinfiltration bei lymphatischen Leukämien. Hämatologie u. Bluttransfusion 8, 159 (1969).Google Scholar
  159. Dennes, E., Tupper, R., Wormall, A.: Zinc content of erythrocytes and leukocytes of normal and leukemic subjects. Nature (Lond.) 187, 302 (1960).CrossRefGoogle Scholar
  160. Desai, D.V., Ezdinli, E.Z., Stutzman, L.: Vincristine therapy of lymphomas and chronic lymphocytic leukemia. Cancer (Philad.) 26, 352 (1970).CrossRefGoogle Scholar
  161. Diamond, L.B.: Leukemic changes in the brain. A report of fourteen cases. Arch. Neurol. Psychiat. (Chic.) 32, 118(1934).Google Scholar
  162. Diamond, H.D., Miller, D.G.: Chronic lymphocytic leukemia. Med. Clin. N. Amer. 45, 601 (1961).PubMedGoogle Scholar
  163. Diamond, H.D., Williams, H.M., Craver, L.F.: The pathogenesis and management of neurological complications of malignant lymphomas and leukemia. Acta Un. int. Cancr. 16, 831 (1960).PubMedGoogle Scholar
  164. Dickler, H.B., Siegal, F.P., Bentwich, Z.H., Kunkel, H.G.: Lymphocyte binding of aggregated IgG and surface Ig staining in chronic lymphocytic leukemia. Clin. exp. Immunol. 14, 97 (1973).PubMedGoogle Scholar
  165. Dixon, F.J., Talmage, D.W., Maurer, P.H.: Radiosensitive and radioresistant phases in the antibody response, J. Immunol. 68, 693 (1952).PubMedGoogle Scholar
  166. Djaldetti, M., de Vries, A., Levie, B., Tikva, P.: Hemolytic anemia in lymphocytic leukemia. Arch, intern. Med. 110, 449 (1962).Google Scholar
  167. Dmochowski, L.: Viruses and mycoplasma (PPLO) in human leukemia. Cancer (Philad.) 18, 1345 (1965).CrossRefGoogle Scholar
  168. Doering, P., Harbers, H., Harbers, E.: Untersuchungen über das Verhalten leukämischer Blutzellen nach in-vivo-Markierung ihrer DNS mit Radiophosphor. Klin. Wschr. 35, 31 (1957).PubMedCrossRefGoogle Scholar
  169. Donner, L., Klener, P.: Lebenserwartung und Heilungschancen der chronischen lymphatischen Leukaemie. In: Leukämien und maligne Lymphome (A. Stacher, Hrsg.), S. 528. Wien: Urban u. Schwarzenberg 1973.Google Scholar
  170. Dorfman, R.F.: Classification of non-Hodgkin’s lymphomas. Lancet 1974I, 1295.Google Scholar
  171. Dorsey, P.W.: Bone changes in leukemia. Mich. St. Med. Soc. 53, 153 (1954).Google Scholar
  172. Dougherty, T.F., Berliner, M.L., Berliner, D.L.: Hormonal control of lymphocyte production and destruction. In: Progress in Hematology (L.M. Tocantins, Ed.), p. 155. New York-London: Grune & Stratton 1962.Google Scholar
  173. Dougherty, T.F., White, A.: Functional alterations in lympoid tissue induced by adrenal cortical secretion. Amer. J. Anat. 77, 81 (1945).CrossRefGoogle Scholar
  174. Douglas, S.D., Cohnen, G., König, E., Brittinger, G.: Lymphocyte lysosomes and lysosomal enzymes in chronic lymphocytic leukemia. Blood 41, 511 (1973).PubMedGoogle Scholar
  175. Drings, P., Brock, N., Burckert, H., Gerhartz, H., Paulisch, R.: Erfahrungen mit neuartigen N-Lost-Phosphamidestern. Dtsch. med. Wschr. 95, 491 (1970).PubMedCrossRefGoogle Scholar
  176. Dubois-Ferriere, H.: Arzneimittel-Forsch. 11, 202 (1961).Google Scholar
  177. Durant, J.R., Finkbeiner, J.A.: „Spontaneous“remission in chronic lymphatic leukemia? Cancer (Philad.) 17, 113 (1964).CrossRefGoogle Scholar
  178. Ebbe, S., Wittels, B., Dameshek, W.: Autoimmune thrombocytopenic purpura („ITP“type) with chronic lymphocytic leukemia. Blood 19, 23 (1962).PubMedGoogle Scholar
  179. Edelson, R.L., Kirkpatrick, C.H., Shevach, E.M., Schein, P.S., Smith, R.W., Green, I., Lutzner, M.: Preferential cutaneous infiltration by neoplastic thymus-derived lymphocytes. Ann. intern. Med. 80, 685 (1974).PubMedGoogle Scholar
  180. Ehrlich, P.: Beiträge zur Kenntnis der Anilinfärbungen und ihrer Verwendung in der mikroskopischen Technik. Arch. mikr. Anat. 13, 263 (1877).CrossRefGoogle Scholar
  181. Eidinger, D., Garrett, T.J.: Studies of the regulatory effects of the sex hormones on antibody formation and stem cell differentiation. J. exp. Med. 136, 1098 (1972).PubMedCrossRefGoogle Scholar
  182. Engelbreth-Holm, J.: Leukaemi og anden malign svulst hos samme patient. Nord. Med. 9, 791 (1941).Google Scholar
  183. Epstein, E., MacEachern, K.: Dermatologic manifestations of the lymphoblastoma-leucemia group. Arch, intern. Med. 60, 867 (1937).Google Scholar
  184. Elves, M.W., Collinge, M., Israels, M.C.: The potential of lymphocytes from patients with leucemia and reticulosis to transform under the influence of phytohaemagglutinin. Acta haemat. (Basel) 37, 100(1967).CrossRefGoogle Scholar
  185. Engelfriet, C.P., v.d. Borne, A.E.G.K., v.d. Giessen, M., Beckers, D., v. Loghem, J.J.: Autoimmune haemolytic anaemias. I. Serological studies with pure anti-immunglobulin reagents. Clin. exp. Immunol. 3, 605 (1968).PubMedGoogle Scholar
  186. Eskeland, T., Klein, E., Inoue, M., Johansson, B.: Characterization of immunoglobulin structures from the surface of chronic lymphocytic leukemia cells. J. exp. Med. 134, 265 (1971).PubMedCrossRefGoogle Scholar
  187. Evans, R.S., Takahashi, K., Duane, R.T., Payne, R., Liu, C.K.: Primary thrombocytopenic purpura and acquired hemolytic anemia: Evidence for a common etiology. Arch, intern. Med. 87, 48 (1951).Google Scholar
  188. Everett, J.L., Roberts, L.R., Ross, W.C.: Aryl-2-Halogeno-Alkylamines: Part XII. Some Carboxylic Derivates of NN-Di-2-chloroethylanine. J. Chem. Soc. (Lond.) 3, 2386 (1953).CrossRefGoogle Scholar
  189. Evers, W.T.: Treatment of leukemia by ECIB with a conventional x-ray machine: A demonstration of four cases. Brit. J. Haemat. 17, 406 (1969).PubMedGoogle Scholar
  190. Ezdinli, E.Z., Stutzman, L.: Chlorambucil therapy for lymphomas and chronic lymphocytic leukemia. J. Amer. med. Ass. 191, 444 (1965).Google Scholar
  191. Ezdinli, E.Z., Stutzman, L., Aungst, W., Firat, D.: Corticosteroid therapy for lymphomas and chronic lymphocytic leukemia. Cancer (Philad.) 23, 900 (1969).CrossRefGoogle Scholar
  192. Faber, M., Borum, K.: Leukaemia and a malignant tumour in the same patient. Brit. J. Haemat. 8, 313 (1962).CrossRefGoogle Scholar
  193. Fahey, J.L.: Antibodies and immunoglobulins. II. Normal development and changes in desease. J. Amer. med. Ass. 194, 255 (1965).CrossRefGoogle Scholar
  194. Fairley, G.H., Scott, R.B.: Hypogammaglobulinaemia in chronic lymphatic leukaemia. Brit. med. J. 1961II, 920.Google Scholar
  195. Fateh-Moghadam, A.: Paraproteinämische Hämoblastosen. In: Handbuch der Inneren Medizin, (H. Begemann, Hrsg.), Bd. II/5. Berlin-Heidelberg-New York: Springer 1974.Google Scholar
  196. Feinleib, M., MacMahon, B.: Variation in the duration of survival of patients with the chronic leukemias. Blood 15, 332 (1960).PubMedGoogle Scholar
  197. Feldmann, M., Basten, A.: Cell interactions in the immune response in vitro. I. Metabolic activities of T-cells in a collaborative antibody response. Europ. J. Immunol. 2, 213 (1972).CrossRefGoogle Scholar
  198. Field, E.O., Sharpe, H.B.A., Dawson, K.B., Andersen, V., Killmann, S.A., Weeke, E.: Turnover rates of normal blood lymphocytes and exchangeable pool size in man, calculated from analysis of chromosomal aberrations sustained during extracorporeal irradiation of the blood. Blood 39, 39 (1972).PubMedGoogle Scholar
  199. Fink, U.: Extrakorporale Blutbestrahlung der Leukämien. Med. Klin. 67, 1465 (1972).PubMedGoogle Scholar
  200. Fink, I.L., Strebel, J., Weig, J., Sepp, F., Rastetter, J., Muller-Berat, N.: Rosettentransformation bei Gesunden und bei Patienten mit chronisch-lymphatischer Leukämie. Verh. dtsch. Ges. inn. Med. 79, 543 (1973).PubMedGoogle Scholar
  201. Fischer, J.: Die Milzszintigraphie als Methode zur funktionellen Milzanalyse. In: Die Milz (K. Lenner, D. Harms, Hrsg.), S. 11. Berlin-Heidelberg-New York: Springer 1970.Google Scholar
  202. Fischer, J.: Hypersplenismus. Internist 12, 176 (1971).PubMedGoogle Scholar
  203. Flashmann, D.H., Leopold, S.S.: Leukosarcoma. Amer. J. med. Sci. 177, 651 (1929).CrossRefGoogle Scholar
  204. Fitzgerald, P.H., Adams, A.: Chromosome studies in chronic lymphocytic leukemia and lymphosarcoma. J. nat. Cancer Inst. 34, 827 (1965).PubMedGoogle Scholar
  205. Fitzgerald, P.H., Hamer, J.W.: Third case of chronic lymphocytic leukemia in a carrier of the inherited Ch1 chromosome. Brit. med. J. 1969II, 752.CrossRefGoogle Scholar
  206. Fitzgerald, P.H., Rastrick, J.M., Hamer, J.W.: Acute plasma cell leukaemia following chronic lymphatic leukaemia: Transformation or two separate diseases? Brit. J. Haemat. 25, 171 (1973).PubMedCrossRefGoogle Scholar
  207. Flad, H.D., Huber, C., Bremer, K., Menne, H.D., Huber, H.: Impaired recirculation of B lymphocytes in chronic lymphocytic leukemia. Europ. J. Immunol. 3, 688 (1973).CrossRefGoogle Scholar
  208. Fliedner, T.M., Bremer, K., Pretorius, F., Drücke, B., Cronkite, E.P., Fache, J.: Utilisation de la thymidine et de la cytidine tritiées pour l’étude du turnover et du metabolisme des lymphocytes chez l’homme. Nouv. Rev. franç. Hémat. 8, 613 (1968).PubMedGoogle Scholar
  209. Fliedner, T.M., Meuret, G.: Die extrakorporale Blutbestrahlung. Klin. Wschr. 49, 895 (1971).PubMedCrossRefGoogle Scholar
  210. Follette, J.H., Valentine, W.N., Lawrence, J.S.: The beta glucusonidase content of human leukocytes in health and disease. J. Lab. Clin. Med. 40, 825 (1952).PubMedGoogle Scholar
  211. Ford, W.L., Gowans, J.L.: The traffic of lymphocytes. Sem. Hemat. 6, 67 (1969).Google Scholar
  212. Ford, W.L.: The mechanism of lymphopenia produced by chronic irradiation of the rat spleen. Brit. J. exp. Path. 49, 502 (1968).PubMedGoogle Scholar
  213. Ford, W.L., Nieuwenhuis, P.: The spleen and lymphocytes. Schweiz, med. Wschr. 104, 1348 (1974).Google Scholar
  214. Forkner, C.E.: Leukemia and Allied Disorders. New York: MacMillan 1938.Google Scholar
  215. Fraumeni, J.F., Miller, R.W.: Epidemiology of human leukemia: Recent observations. J. nat. Cancer Inst. 38, 593 (1967).PubMedGoogle Scholar
  216. Fraumeni, J.F., Vogel, C.L., de Vita, V.T.: Familial chronic lymphocytic leukemia. Ann. Int. Med. 71, 279 (1969).PubMedGoogle Scholar
  217. Freeman, G., Hyde, J.S.: Roles of prothrombin activity, heparinprotamine titer and platelet concentration in bleeding of leukemia. Blood 7, 311 (1952).PubMedGoogle Scholar
  218. Freireich, E.J., Judson, G., Levin, R.H.: Separation and collection of leukocytes. Cancer Res. 25, 1516(1965).PubMedGoogle Scholar
  219. Freymann, J.G., Vander, J.B., Marler, E.A., Meyer, D.B.: Prolonged corticosteroid therapy of chronic lymphocytic leukemia and the closely allied malignant lymphomas. Brit. J. Haemat. 6, 303 (1960).PubMedCrossRefGoogle Scholar
  220. Frindel, E., Malaise, E., Tubiana, M.: Cell proliferation kinetics in five human solid tumours. Cancer 22, 611 (1968).PubMedCrossRefGoogle Scholar
  221. Frischauf, H., Honetz, H., Keibl, E.: Erythrokinetische Untersuchungen mit 59Fe und 51Cr bei chronischen Lymphadenosen. Blut 28, 149 (1968).CrossRefGoogle Scholar
  222. Fröhlich, D., Bock, O.: Ergebnisse bei Langzeitbehandlung chronischer Lymphadenosen mit extrakorporaler Blutbestrahlung. Verh. dtsch. Ges. Inn. Med. 79, 524 (1973).PubMedGoogle Scholar
  223. Fröland, S.S.: Binding of sheep erythrocytes to human lymphocytes. A probable marker of T-lymphocytes. Scand. J. Immunol. 1, 269 (1972).PubMedCrossRefGoogle Scholar
  224. Fudenberg, H., Solomon, A.: Acquired Agammaglobulinemia with autoimmune hemolytic disease: Graft-versus host reaction? Vox Sang (Basel) 6, 68 (1961).CrossRefGoogle Scholar
  225. Fuller, H.W.: Particulars of a case in which enormous enlargement of the spleen and liver, together with dilatation of all the bloodvessels of the body, were found coincident with a peculiarly altered condition of the blood. Lancet 1846II, 43.Google Scholar
  226. Gall, E.A., Mallory, T.B.: Malignant lymphoma. A clinicopathologic survey of 618 cases. Amer. J. Path. 18, 381 (1942).PubMedGoogle Scholar
  227. Gallagher, T.F., Bradlow, H.L., Miller, D.G., Zumoff, B., Hellman, L.: Steroid hormone metabolism in chronic lymphatic leukemia. Clin. Endocr. 22, 1049 (1962).CrossRefGoogle Scholar
  228. Galton, D.A.G.: (Thesis). University of Cambridge 1963.Google Scholar
  229. Galton, D.A.G.: Management of the chronic leukemias. Rec. Res. Cancer Res. 36, 147 (1971).Google Scholar
  230. Galton, D.A.G.: The pathogenesis of chronic lymphocytic leukemia. Canad. med. Ass. J. 94, 1005 (1966).PubMedGoogle Scholar
  231. Galton, D.A.G., Wiltshaw, E., Szur, L., Dacie, I.V.: Use of chlorambucil and steroids in treatment of chronic lymphocytic leukemias. Brit. J. Haemat. 7, 73 (1961).PubMedCrossRefGoogle Scholar
  232. Garret, J.V., Lajtha, L.G.: Quatre cas de leucemie lymphoide chronique traites par irradiation extracorporelle du sang. Nouv. Rev. franç. Hemat. 8, 701 (1968).Google Scholar
  233. Garvin, A.J., Spicer, S.S., Parmley, R.T., Munster, A.M.: Immunohistochemical demonstration of IgG in Reed-Sternberg and other cells in Hodgkin’s disease. J. exp. Med. 139, 1077 (1974).PubMedCrossRefGoogle Scholar
  234. Gasteiger, H.: Über Augenbefunde bei aleukämischer Lymphadenose. Z. inn. Med. 10, 973 (1955).Google Scholar
  235. Gehrmann 1969.Google Scholar
  236. Gerard-Marchant, R., Hamlin, I., Lennert, K., Rilke, F., Stansfeld, A.G., v. Unnig, J.A.M.: Letter to the editor. Lancet 1974II, 406.Google Scholar
  237. Gerhartz, H.: Vergleichende Untersuchungen zur Toxizität und Seitenwirkung moderner Zytostatika. Verh. dtsch. Ges. inn. Med. 68, 251 (1962).Google Scholar
  238. Gerhartz, H.: Chemotherapie der chronischen Lymphozytenleukämie. Med. Klin. 62, 1237 (1967).PubMedGoogle Scholar
  239. Gerhartz, H., Algenstaedt, D., Kessel, J.: Grundlagen zur Chemotherapie mit Endoxan. Internist 1, 278 (1960).PubMedGoogle Scholar
  240. Ghiotto, G., Perona, G., Dasandre, G., Cortesi, S.: Hexokinase and TPN-dependent dehydrogenase of leukocytes in leukemia and other hematological disorders. Brit. J. Haemat. 9, 345 (1963).PubMedCrossRefGoogle Scholar
  241. Gilman, A., Philips, F.S.: The biologic actions and therapeutic applications of the chloraethyl amines and sulfides. Science 103, 409 (1946).CrossRefGoogle Scholar
  242. Girardet, R.E., Benninghoff, D.L.: Thoracic duct lymph and lymphocyte studies in man using a thoracic duct „side-fistula“. Cancer 29, 666 (1972).PubMedCrossRefGoogle Scholar
  243. Goh, K.O.: Pseudodiploid chromosomal patten in chronic lymphocytic leukemia. J. Lab. clin. Med. 69, 938 (1967).PubMedGoogle Scholar
  244. Goldbach, L.J.: Leukemic retinitis. Arch. Ophtal. (Chic.) 10, 808 (1933).Google Scholar
  245. Gorman, J.G., Chandler, J.G.: Is there an immunologically incompetent lymphocyte. Blood 23, 117(1964).Google Scholar
  246. Goldberg, A.F.: Acid phosphatase activity in cells of acute and chronic leukemia and multiple myeloma. Clin. Res. 15, 278 (1967).Google Scholar
  247. Goldberg, G.M., Emanuel, B.: A study of malignant lymphomas and leukemias. VII. Lymphogenous leukemia and lymphosarcoma involvement of the lymphatic and hemic bed, with references to differentiating criteria. Cancer 17, 277 (1964).PubMedCrossRefGoogle Scholar
  248. Good, R.A.: Lymphocyte surface markers. New Engl. J. Med. 287, 305 (1972).PubMedCrossRefGoogle Scholar
  249. Gowans, J.L., Knight, E.J.: The route of re-circulation of lymphocytes in the rat. Proc. Roy. Soc. B. 159, 257(1964).CrossRefGoogle Scholar
  250. Graetz, F.: Über lymphatische Leukämie mit besonderer Berücksichtigung ihrer großzelligen Form. Beitr. path. Anat. 49, 338 (1910).Google Scholar
  251. Graf, F., Buzasi, G., Takacsi-Nagy, L., Jakab, I.: R-74-Therapie maligner Lymphome. In: Leukämien und maligne Lymphome (A. Stacher, Hrsg.), S. 392. München-Berlin-Wien: Urban & Schwarzenberg 1973.Google Scholar
  252. Greaves, M., Janossy, G.: Elicitation of selective T and B lymphocyte responses by cell surface binding ligands. Transplant. Rev. 11, 87 (1972).PubMedGoogle Scholar
  253. Greaves, M.F., Owen, J.J.T., Raff, M.C.: T and B Lymphocytes. Origins, Properties and Roles in Immune responses. Amsterdam: Excerpta Medica 1974.Google Scholar
  254. Green, R.A., Dixon, H.: Expectancy for life in chronic lymphatic leukemia. Blood 25, 23 (1965).PubMedGoogle Scholar
  255. Greenberg, M., Chanana, A.D., Cronkite, E.P., Schiffer, L.M., Stryckmans, P.A.: Tritiated thymidine as a cytocidal agent in human leukemia. Blood 28, 851 (1966).PubMedGoogle Scholar
  256. Greig, H.B.W., Metz, J., Laird, M.H., Zentkowsky, D., Fitzpatrick, M.M.F.: Chemotherapy of leukaemia II. Puri-Nethol in the treatment of acute leukaemia and some other neoplastic diseases of the reticulo-endothelial system. S. Afr. med. J. 30, 360 (1956).PubMedGoogle Scholar
  257. Grey, H.M., Rabellino, E., Pirowsky, B.: Immunoglobulins on the surface of lymphocytes. IV. Distribution in hypogammaglobulinaemia, cellular immune deficiency and chronic lymphatic leucemia. J. clin. Invest. 50, 2368 (1971).PubMedCrossRefGoogle Scholar
  258. Gross, R., Wildhack, R., Steiner, H.: Klinisch-statistische Übersicht über 900 Leukosen. Dtsch. med. Wschr. 83, 1974(1958).PubMedCrossRefGoogle Scholar
  259. Grundmann, E.: Zur Morphologie der Lymphocyten. Schweiz, med. Wschr. 91, 1186 (1961).Google Scholar
  260. Grundmann, E.: Die Rolle der Lymphozyten bei der Wahrung der individuellen Integrität. In: Lymphozyt und klinische Immunologie (H. Theml, H. Begemann, Hrsg.). Berlin-Heidelberg-New York: Springer 1975.Google Scholar
  261. Gunz, F.W., Fitzgerald, P.H., Adams, A.: An abnormal chromosome in chronic lymphocytic leukemia. Brit. med. J. 1962 II, 1097.Google Scholar
  262. Gunz, F.W., Veale, A.M.O.: Leukemia in close relatives-accident or predisposition? J. Nat. Cancer Inst. 42, 517 (1969).PubMedGoogle Scholar
  263. Haas, R.M., Bohne, F., Fliedner, T.M.: Die Wirkung kontinuierlicher intrazellulärer Bestrahlung durch 3H-Thymidin auf schwangere Ratten und auf die Entwicklung ihrer Nachkommenschaft. Strahlentherapie 139, 571 (1970).PubMedGoogle Scholar
  264. Hale, A.J., Wilson, L.J.: Lancet 1960I, 577. Zit. nach Harwerth et al., 1963.Google Scholar
  265. Hallen, J.: Discrete Gammaglobulin (M-) Components in Serum, Clinical Study of 150 Subjects without Myelomatosis. Acta med. scand., Suppl. 462, 71 (1966).Google Scholar
  266. Hamilton, L.D.: Nucleic acid turnover studies in human leukaemic cells and the function of lymphocytes. Nature 178, 597 (1956).PubMedCrossRefGoogle Scholar
  267. Han Tin: Chronic lymphocytic leukemia in Hodgkin’s disease. Cancer 28, 300 (1971).PubMedCrossRefGoogle Scholar
  268. Han, T., Ezdinli, E.Z., Shimaoka, K., Desai, D.V.: Chlorambucil vs. combined. Chlorambucil-Corticosteroid therapy in chronic lymphocytic leukemia. Cancer 31, 502 (1973).PubMedCrossRefGoogle Scholar
  269. Han, T., Ezdinli, E.Z., Sokal, J.E.: Complete remission in chronic lymphocytic leukemia and leukolymphosarcoma. Cancer 26, 243 (1967).CrossRefGoogle Scholar
  270. Hannemann, H.R.: Steroidtherapie mit ACTH oder Corticoiden? Med. Klin. 69, 513 (1974).PubMedGoogle Scholar
  271. Hansen, M.M.: Chronic lymphocytic leucemia. Scand. J. Haemat., Suppl. 18 (1973).Google Scholar
  272. Hardin, E.B., Valentine, W.N., Follette, J.H., Lawrence, J.S.: Studies on the sulfhydryl content of human leukocytes and erythrocytes. Amer. J. med. Sci. 228, 73 (1954).PubMedCrossRefGoogle Scholar
  273. Harrington, W.I., Arimura, G.: Immune reactions of platelets. In: Blood Platelets (S.A. Johnson et al., Eds.). Boston: Little, Brown & Co. 1961.Google Scholar
  274. Hartmann, K.U.: In vitro studies of cellular cooperation during immune induction. In: The Role of Lymphocytes and Macrophages in the Immunological Response (D.C. Dumonde Ed.), p. 22. Berlin-Heidelberg-New York: Springer 1971.Google Scholar
  275. Harwerth, H.G., Schmitt, H.E., Obrecht, P.: Akute und chronische Lymphadenose. In: Handb. d. ges. Hämatologie. Bd. IV. München: Urban & Schwarzenberg 1963.Google Scholar
  276. Havemann, K., Kuni, H., Schmidt, W., Malchow, H.: Untersuchungen über die Wirkung von Antilymphozytenserum bei chronischen Lymphadenosen. In: Chemo- und Immunotherapie der Leukosen und malignen Lymphome (A. Stacher, Hrsg.), S. 536. Wien: Bohmann 1969.Google Scholar
  277. Havemann, K., Rubin, A.D.: The delayed response of chronic lymphocytic leukemia lymphocytes to PHA in vitro. Proc. Soc. exp. Biol. (N.Y.) 127, 668 (1968).Google Scholar
  278. Hayhoe, F.G.J.: The cytochemical demonstration of lipids in blood and bone marrow cells. J. Path. Bact. 65, 413 (1953).PubMedCrossRefGoogle Scholar
  279. Hayhoe, F.G.J.: Leukaemia. Research and Clinical Practice. London: J.&A. Churchill 1960.Google Scholar
  280. Heilmeyer, L., Begemann, H.: Blut und Blutkrankheiten. In: Handbuch der Inneren Medizin (G. v. Bergmann, W. Frey, Hrsg.), 4. Aufl. Bd. 2. Berlin-Göttingen-Heidelberg: Springer 1951.Google Scholar
  281. Heilmeyer, L., Heilmeyer, I.: Triäthylenmelanin (TEM), ein neuer Stoff zur Behandlung von Leukaemien. Ergebnisse einer Prüfung an 29 Fällen. Klin. Wschr. 30, 537 (1952).PubMedCrossRefGoogle Scholar
  282. Heilmeyer, L., Keiderling, W.: Blutkrankheiten. In: Künstliche radioaktive Isotope in Psychologie, Diagnostik und Therapie (H. Schwiegk, F. Turba, Hrsg.), Bd. 2, S. 833. Berlin-Göttingen-Heidelberg: Springer 1961.Google Scholar
  283. Heilmeyer, L., Mössner, G., Hess, K.: Die lymphatische Leukämie. Klin. Wschr. 37, 790 (1959).PubMedCrossRefGoogle Scholar
  284. Heine, K.M.: Funktion und Funktionsprüfung des lymphatischen Systems. Berlin: Akademie-Verlag 1973.Google Scholar
  285. Heine, K.M., Stobbe, H., Hofer, E., Weber, H.: Lymphozytentransformation bei chronischer lymphatischer Leukose unter Berücksichtigung der absoluten Lymphozytenzahl im Blut. Acta haemat. (Basel) 41, 144 (1969).CrossRefGoogle Scholar
  286. Heineke, H.: Experimentelle Untersuchungen über die Einwirkung der Röntgenstrahlen auf innere Organe. Mitt. Grenzgeb. Med. Chir. 14, 21 (1905).Google Scholar
  287. Heiniger, H.J., Feinendegen, L.E., Bürki, K.: Reutilization of thymidine in various groups of rat bone marrow cells. Blood 37, 340 (1971).PubMedGoogle Scholar
  288. Heinivaara, O., Kaipainen, W.J.: Pelger-Huet anomaly in lymphocytic leukaemia. Acta haemat. (Basel) 25, 375 (1961).CrossRefGoogle Scholar
  289. Helmbrecht, H.: Statistische Untersuchungen an 110 Patienten mit chronischer lymphatischer Leukämie. Inaugural-Dissertation, München 1976.Google Scholar
  290. Helbig, W., Mühl, H.: Ergebnisse der Cyclophosphamidtherapie bei Einzel- und Stoßbehandlung. Z. inn. Med. 22, 811 (1967).Google Scholar
  291. Hellström, J.: Ein Fall von Hämaturie infolge eines leukämischen Infiltrates in der Urethra. Z. Urol. 28, 290 (1934).Google Scholar
  292. Hermann, H.B., Goldberg, M., Salerno, F.M.: Leukemic infiltration of the bladder neck in a female patient. J. Urol. 83, 51 (1960).PubMedGoogle Scholar
  293. Heuchel, G., Dahl v., D.: Leukämie und Niere. Blut 5, 390 (1959).PubMedCrossRefGoogle Scholar
  294. Heymans, J.F.: Iso, hyper et hypothermisation des mammiferes par calorification et frigorification du sang de la circulation carotidjugulaire anastomosee. Arch. int. Pharmacodyn. 25, 1 (1921).Google Scholar
  295. Heyssel, R., Brill, A.B., Woodbury, L.A., Nishimura, E.T., Ghose, T., Hoshino, T., Yamasaki, M.: Leukemia in Hiroshima atomic bomb survivors. Blood 15, 313 (1960).PubMedGoogle Scholar
  296. Hirschhorn, K., Schreibman, R.R., Bach, F.H., Sitzbach, L.E.: In vitro studies on lymphocytes from patients with sarcoidosis and lymphoproliferative diseases. Lancet 1964 II, 842.Google Scholar
  297. Hittmair, A.: Die krankheitsdominante Milz. Folia haemat. (Lpz.) 70, 163 (1950).Google Scholar
  298. Hittmair, A.: Physiologie und Pathologie der Milz. München-Berlin-Wien: Urban & Schwarzenberg 1969.Google Scholar
  299. Hitzig, W.H., Rampini, S.: Leukämie bei Zwillingen. Helvet. Paediat. Acta 14, 67 (1959).Google Scholar
  300. Höcker, P., Haist, B., Gobets, M.A., Stacher, A.: Die PHA-Stimulierung bei chronischen Lym-phomatosen vor und nach Leukophorese mit dem Zellseparator. 4. Internat. Arbeitstagung über Leukozytenkulturen, Abstr. Innsbruck, März 1973.Google Scholar
  301. Hoffmann, L., Taubert, M.: Zur Frage der medullären Verlaufsform chronisch lymphatischer Leukaemien. Medizinische 2, 1865 (1958).Google Scholar
  302. Holbøll, S.A.: Untersuchungen über den Grundumsatz bei Patienten mit Leukämie und Lymphogranulomatose. Acta med. scand. 72, 326 (1929).CrossRefGoogle Scholar
  303. Hollard, D., Suscillon, M., Patet, J., Schaerer, R.: Cytological and cytogenic study of lymphocytes during treatment of chronic lymphocytic leukemia by ECIB. Brit. J. Haemat. 17, 410 (1969).Google Scholar
  304. Holmes, F.F., Westphal, D.M.: Survival in treated an untreated chronic lymphocytic leukemia 1942–1968. Oncology 25, 137 (1971).PubMedCrossRefGoogle Scholar
  305. Hotchkiss, H.D.: A microchemical reaction resulting in the staining of polysaccharide structures in fixed tissue preparations. Arch. Biochem. 16, 131 (1948).PubMedGoogle Scholar
  306. Huhn, D., Kaboth, W., Theml, H., Murr, H., Schramm, W., Leisner, B.: Blut- und Blutgerinnungsveränderungen durch die extrakorporale Bestrahlung der Leukämie und durch die Radiophosphortherapie bei Polyzythämie. In: Strahlen, Blutgerinnung und Hämostase (R. Marx, H.A. Thies, Hrsg.). Stuttgart-New York: Schattauer 1974.Google Scholar
  307. Hui, C.Y.: Über den Glykogengehalt der Blutzellen bei myeloproliferativen Erkrankungen mit besonderer Berücksichtigung der alkalischen Phosphatase. Med. Diss., Freiburg i.Brsg. 1962.Google Scholar
  308. Hurez, D., Flandrin, G., Preud’Homme, J.-L., Seligmann, M.: Unreleased intracellular monoclonal macroglobulin in chronic lymphocytic leukaemia. Clin. exp. Immunol. 10, 223 (1972).PubMedGoogle Scholar
  309. Hyman, G.A.: Increased incidence of neoplasia in association with chronic lymphocytic leukaemia. Scand. J. Haemat. 6, 99 (1969).PubMedCrossRefGoogle Scholar
  310. Hougie, C.: The early diagnosis and natural history of chronic lymphatic leucemia. Ann. intern. Med. 45, 39 (1956).PubMedGoogle Scholar
  311. Howard, J.C.: The life span and recirculation of marrow-derived small lymphocytes from the rat thoracic duct. J. exp. Med. 135, 185 (1972).PubMedCrossRefGoogle Scholar
  312. Huber, Ch., Huber, H., Menne, H.D., Asammer, H., Flad, H.D., Bremer, K.: Gestörte B-Zellrezir-kulation bei chronischer Lymphadenose. In: Verh. dtsch. Ges. Inn. Med. 79, 547 (1973).Google Scholar
  313. Huber, Ch., Huber, H., Schmalzl, F., Lederer, B., Hüttrich, B., Braunsteiner, H.: DNS-synthetisierende Blutlymphozyten beim malignen Lymphogranulom. Acta haemat. (Basel) 44, 222 (1970).Google Scholar
  314. Huber, Ch., Kurz, R., Asamer, H., Huber, H., Braunsteiner, H.: Die Differenzierung menschlicher Blutlymphocyten mit serologischen und autoradiographischen Methoden. Klin. Wschr. 52, 127 (1974).PubMedCrossRefGoogle Scholar
  315. Huber, Ch., Michlmayr, G., Huber, H.: Immunologische Marker in der Differentialdiagnose lymphatischer Systemerkrankungen. Dtsch. med. Wschr. 99, 2262 (1974).PubMedCrossRefGoogle Scholar
  316. Huber, H., Huber, Ch., Michlmayr, G.: Immunpathologie bei lymphatischen Systemerkrankungen. Verh. dtsch. Ges. inn. Med. 79, 159 (1973).PubMedGoogle Scholar
  317. Huber, H., Pathouli, Ch., Michlmayr, G.: Immunpathologie lymphatischer Systemerkrankungen. In: Lymphozyt und klinische Immunologie (H. Theml, H. Begemann, Hrsg.). Berlin-Heidelberg-New York: Springer 1975.Google Scholar
  318. Huguley, C.M.: Long term study of chronic lymphocytic leukemia. Interimport after 45 month. Cancer Chemother. Rep. 16, 241 (1962).Google Scholar
  319. Huhn, D.: Feinstruktur peripherer Lymphozyten bei chronisch lymphatischer Leukämie. Dtsch. med. Wschr. 95, 897 (1970).PubMedCrossRefGoogle Scholar
  320. Isaacs, R.: Lymphosarcoma cell leukemia. Ann. intern. Med. 11, 657 (1937).Google Scholar
  321. Ivanyi, J., Sochman, J., Ivanyi, P.: Haptoglobin Level in Haemoblastoses. Acta haemat. (Basel) 25, 98 (1961).CrossRefGoogle Scholar
  322. Iversen, L.G.: Phytohemagglutinin response of recirculating and non-recirculating rat lymphocytes. Exp. Cell. Res. 50, 219 (1969).CrossRefGoogle Scholar
  323. Jago, M.: The radiosensivity of normal and leukemic human blood lymphocytes. Clin. Radiol. 12, 59 (1961).PubMedCrossRefGoogle Scholar
  324. Javett, S.L., Tefft, M., Drummond, C.P., Levitan, R.: Leukemic infiltration of the sigmoid colon. Amer. J. dig. Dis. 8, 299 (1963).CrossRefGoogle Scholar
  325. Jeannet, M., Magnin, C.: H.L-A antigens in hematological malignant diseases. Transplant. Proc. 3, 1301 (1971).Google Scholar
  326. Jensen, K.B.: Anaemia in Hodgkin’s diesease and chronic lymphatic leukaemia. Dan. med. Bull. 4, 150 (1957).PubMedGoogle Scholar
  327. Johnson, R.E.: Radiosensitivity of leukemic and non-leukemic lymphocytes. Cancer Res. 27, 39 (1967).PubMedGoogle Scholar
  328. Johnson, R.E.: Total body irradiation of chronic lymphocytic leukemia: incidence and duration of remission. Cancer 25, 523 (1970).PubMedCrossRefGoogle Scholar
  329. Johnson, R.E., Kagan, A.R., Gralnick, H.R., Fass, L.: Radiation-induced remissions in chronic lymphocytic leukemia. Cancer (Philad.) 20, 1382 (1967).CrossRefGoogle Scholar
  330. Johnson, D.M., Pratt, P.T., Rigby, P.G.: An evaluation of human lymphocyte nuclear RNA with acridine orange. Blood 29, 800 (1967).PubMedGoogle Scholar
  331. Johnson, C.E., Soule, E.H.: Malignent lymphoma as a gynecologic problem. Report of five cases including one primary lymphosarcoma of the cervix uteri. Obstet, gynec. Surv. 9, 149 (1957).Google Scholar
  332. Kagan, A.R., Johnson, R.E.: Evaluation of therapy in chronic lymphocytic leukemia using in vitro lymphocyte transformation. Radiology 88, 352 (1967).PubMedGoogle Scholar
  333. Kaplan, J., Mastrangelo, R., Peterson, W.D.: Childhood lymphoblastic lymphoma, a cancer of thymus derived lymphocytes. Cancer Res. 34, 521 (1974).PubMedGoogle Scholar
  334. Kaplow, L.S.: Alkaline phosphatase activity in peripheral blood lymphocytes. Arch. Path. 88, 69 (1969).PubMedGoogle Scholar
  335. Kappeler, R., Krebs, A., Riva, G.: Klinik der Makroglobulinämie Waldenstrom. Beschreibung von 21 Fällen und Übersicht der Literatur. Helv. med. Acta 25, 54 (1958).PubMedGoogle Scholar
  336. Kappeler, H., Schwyzer, R.: Die Synthese eines Tetracosapeptides mit der Aminosäuresequenz eines hochaktiven Abbauproduktes des β-Corticotropins (ACTH) aus Schweinehypophysen. Helv. chim. Acta 44, 1136 (1961).CrossRefGoogle Scholar
  337. Karl, H.J.: Adrenocorticotrope Wirkungeines vollsynthetischen Tetracosapeptids — ß 1 σ 24 Cortiso-trophin — beim Menschen. Klin. Wschr. 41, 633 (1963).CrossRefGoogle Scholar
  338. Karl, H.J., Raith, L.: Die Corticosteronsekretion beim Menschen. III. Mitteilung. Die Sekretionsraten von Corticosteron und Cortisol bei Stimulierung der Nebennierenrinde mit ACTH. Klin. Wschr. 44, 303 (1966).PubMedCrossRefGoogle Scholar
  339. Karnofsky, D.A., Burchenal, J.H., Armistead, G.C., Southam, C.M., Bernstein, J.L., Craver, L.F., Rhodas, C.P.: Triethylene melamine in the treatment of neoplastic disease. Arch, intern. Med. 87, 477 (1951).Google Scholar
  340. Kato, K., Brunschwig, A.: Acute leukemia following lymphosarcoma. Arch, intern. Med. 51, 77 (1933).Google Scholar
  341. Katayama, I., Finkel, H.E.: Leukemic reticuloendotheliosis. A clinicopathologic study with review of the literature. Amer. J. Med. 57, 115 (1974).PubMedCrossRefGoogle Scholar
  342. Kaung, D.T., Buchman, E.: Chronic lymphocytic leucemia. A clinical study of thirtyfive cases. J. Iowa St. med. Soc. 51, 333 (1961).Google Scholar
  343. Kaur, J., Spiers, A.S., Catovsky, D., Galton, D.A.G.: Increase of T-lymphocytes in the spleen in Hodgkin’s disease Lancet 1974 II, 800.Google Scholar
  344. Kennedy, B.J.: Androgenic hormone therapy in lymphatic leukemia. J. Amer. med. Ass. 190, 1130 (1964).Google Scholar
  345. Kennedy, B.J., Gilbertsen, S.: Increased erythropoiesis induced by androgenic hormone therapy. New Engl. J. Med. 256, 719 (1957).PubMedCrossRefGoogle Scholar
  346. Kennedy, B.J., Theologides, A.: Uracil mustard, a new alkylating agent for oral administration in the management of patient with leukemia and lymphoma. New Engl. J. Med. 264, 790 (1961).PubMedCrossRefGoogle Scholar
  347. Kersey, J.A., Sabad, A., Gajl-Peczalska, K., Hellgren, H.M., Yunis, E.J., Nesbit, M.E.: Acute lymphoblastic leukemic cells with T (thymus-derived) lymphocyte markers. Science 182, 1355 (1973).PubMedCrossRefGoogle Scholar
  348. Keuning, F.J., van der Meer, J., Niewenhuis, P., Oudendijk, P.: The histophysiology of the antibody response. II. Antibody responses and splenic plasma cell reactions in sublethally x-irra-diated rabbits. Lab. Invest. 12, 156 (1963).PubMedGoogle Scholar
  349. Killmann et al.: Acta haemat. (Basel) 25, 81 (1961).Google Scholar
  350. Killmann, S.A., Cronkite, E.P., Fliedner, T.M., Bond, V.P.: Cell prliferation in multiple myeloma studied with tritiated thymidine in vivo. Lab. Invest. 11, 845 (1962).PubMedGoogle Scholar
  351. Kincade, P.W., Cooper, M.D.: Development and distribution of immunoglobulin-containing cells in the chicken. J. Immunol. 106, 371 (1971).PubMedGoogle Scholar
  352. Kissmeyer-Nielsen, F.: Thrombopoieses. (Thesis). Aarhus: Universitetsforlaget 1954.Google Scholar
  353. Klatte, E.C., Yardley, J., Smith, E.B., Rohn, R., Campbell, J.A.: The pulmonary manifestations and complications of leukemia. Amer. J. Roentgenol. 89, 598 (1963).PubMedGoogle Scholar
  354. Klein, H.O., Gross, R., Lennartz, K.J.: Untersuchungen zur Proliferationskinetik und Synchronisation menschlicher Tumorzellen und ihre Bedeutung für die zytostatische Therapie. Verh. dtsch. Ges. inn. Med. 77, 738 (1971).PubMedGoogle Scholar
  355. Klein, H.O., Lennartz, K.J.: Proliferationskinetische Grundlagen der Behandlung akuter Leukosen. In: Leukämie (R. Gross, J. v.d. Loo, Hrsg.), S. 479. Berlin-Heidelberg-New York: Springer 1972.Google Scholar
  356. Klima, R.: Grundlagen für eine Neuordnung der Hämatologie zellulärer Reaktionen im lymphatischen Apparat. Wien. Z. inn. Med. 33, 125 (1952).PubMedGoogle Scholar
  357. Klima, R., Rettenbacher-Däubner, H., Rieder, H.: Antikörpermangel bei malignen Blutkrankheiten. Wien. klin. Wschr. 74, 408 (1962).PubMedGoogle Scholar
  358. Klima, R., Seyfried, H.: Lymphatische Leukaemie unter dem Bild der thrombopenischen Purpura, hämolytischen bzw. aplastischen Anämie und Agranulozytose. Wien. Arch. inn. Med. 30, 1 (1937).Google Scholar
  359. Knapp, W., Schuitt, H.R.E., Bolhuis, R.L.H., Humans, W.: Surface immunoglobulins in chronic lymphatic leukaemia, macroglobulinaemia and myelomatosis. Clin. exp. Immunol. 16, 541 (1974).Google Scholar
  360. Knolle, J., Wörz, R., Meyer z. Büschenfelde: Immunglobulinbestimmungen als Verlaufsbeobachtung bei hämatologischen Erkrankungen unter zytostatischer Therapie. Verh. dtsch. Ges. inn. Med. 75, 492 (1969).PubMedGoogle Scholar
  361. Knospe, W.H., Loeb, V., Huguley, C.H.: Bi-weekly chlorambucil treatment of chronic lymphocytic leukemia. Cancer 33, 555 (1974).PubMedCrossRefGoogle Scholar
  362. Knox, G.: Epidemiology of childhood leukaemia in Northumberland and Durham. Brit. J. prev. soc. Med. 18, 17 (1964).Google Scholar
  363. König, E., Brittinger, G., Cohnen, G.: Relation of lysosomal fragility in CLL lymphocytes to PHA reactivity. Nature New Biol. 244, 247 (1973).PubMedGoogle Scholar
  364. König, E., Cohnen, G., Aberle, H.G., Brittinger, G.: Lysosomale Enzyme in Lymphozyten. II. Acta haemat. (Basel) 44, 265 (1970).CrossRefGoogle Scholar
  365. Kovacs, L.: Histologische Untersuchungen der Milzveränderungen nach experimenteller fraktionierter lokaler Röntgenbestrahlung. Strahlentherapie 142, 711 (1971).PubMedGoogle Scholar
  366. Krakoff, L.H.: Urinary uric acid excretion in leukemia. In: The Leukemias: Etiology, Pathophysiology and Treatment (J.W. Rebuck, F.H. Bethell, R.W. Monto, Eds.), p. 401. New York: Academic Press 1957.Google Scholar
  367. Krantz, C.I., Riddle, M.C.: The basal metabolism in chronic lymphatic leukemia. Amer. J. med. Sci. 175, 229 (1928).CrossRefGoogle Scholar
  368. Krumbhaar, E.B.: The lymphomatoid diseases. J. Amer. med. Ass. 106, 286 (1936).Google Scholar
  369. Kuang, D.T., Whittington, R.M., Patno, M.E., and Veteran’s Administration Cancer Chemotherapy Study Group: Chemotherapy of chronic lymphocytic leukemia. Arch, intern. Med. 114, 521 (1964).Google Scholar
  370. Kubo, R.J., Grey, H.M., Pirofsky, B.: IgD, a major immunoglobulin on the surface of lymphocytes from patients with chronic lymphocytic leukemia. J. Immunol. 112, 1882 (1974).Google Scholar
  371. Kundrat, H.: ÜberLympho-Sarkomatosis. Wien. klin. Wschr. 6, 211 (1893).Google Scholar
  372. Kutarna, A.: Der Chylothorax bei Leukämie. Neoplasma 9, 93 (1962).PubMedGoogle Scholar
  373. Kyle, R.A., McParland, C.E., Dameshek, W.: Large doses of prednisone and prednisolone in the treatment of malignant lymphoproliverative disorders. Ann. intern. Med. 57, 717 (1962).PubMedGoogle Scholar
  374. Lajtha, L.G., Olivier, R., Lewis, C.L., Gunning, A.J., Sharp, A.A., Callender, S.H.: Extracorporeal irradiation of the blood, a possible therapeutic measure. Lancet 1962 I, 333.Google Scholar
  375. Laszlo, J., Gerber, H.J., Sommer, J.R.: Composition and structure of cytoplasmic globules in leukemic lymphocytes. Blood 29, 77 (1967).PubMedGoogle Scholar
  376. Lawrence, J.H.: The treatment of chronic leukemia. Med. Clin. N. Amer. 38, 525 (1954).Google Scholar
  377. Lawrence, J.H., Donald, W.G.: The incidence of cancer in chronic leukemia and in polycythemia vera. Amer. med. Sci. 237, 488 (1959).CrossRefGoogle Scholar
  378. Leavell, B.S.: Chronic leukemia: A study of the incidence and factors influencing duration of life. Amer. J. med. Sci. 196, 329 (1938).CrossRefGoogle Scholar
  379. Lee, S.L., Rosenthal, N., Rosenthal, R.L.: Reticulum cell leukemia. Clinical and hematologic entity. N.Y. St. J. Med. 69, 422 (1969).Google Scholar
  380. Leibetseder, F.: Zur Behandlung der chronischen Lymphadenosen durch Splenektomie. Proc. VII. Int. Congr. Internat. Soc. Hematology, Rom 1958.Google Scholar
  381. Leibetseder, F., Tuba, J.: Splenektomie bei Lymphomen. Folia haemat. (N.F.) 1, 116 (1956).Google Scholar
  382. Leidler, F., Russell, W.O.: The brain in leukemia. A clinicopathologic study of twenty cases with a review of the literature. Arch. Path. 49, 14 (1945).Google Scholar
  383. Lennert, K.: Pathologie der Halslymphknoten. Ein Abriß für Pathologen, Kliniker und praktizierende Ärzte. Berlin-Heidelberg-New York: Springer 1964.Google Scholar
  384. Lennert, K.: Classification of malignant lymphomas (European concept). In: Progress in Lympho-logy (A. Rüttimann, Ed.). Stuttgart: Thieme 1967.Google Scholar
  385. Lennert, K.: Pathologisch-histologische Klassifizierung der malignen Lymphome. In: Leukämien und maligne Lymphome (A. Stacher, Hrsg.). München-Berlin-Wien: Urban & Schwarzenberg 1973.Google Scholar
  386. Lennert, K.: Referat Deutsche Lymphomarbeitsgruppe. Würzburg 1974.Google Scholar
  387. Lennert, K.: Vortrag Deutsche Lymphomarbeitsgruppe. Essen 1975.Google Scholar
  388. Lewis, F.B., Schwartz, R.S., Dameshek, W.: X-Radiation and alkylating agents as possible „trigger“mechanism in the autoimmune complications of malignant lympho-proliferative disease. Clin. exp. Immunol. 1, 3 (1966).PubMedGoogle Scholar
  389. Libansky, J.: Immunologische Reaktivität vom verzögerten Typ bei Kranken mit malignen Bluter-krankungen. In: Chemo- und Immunotherapie der Leukosen und malignen Lymphomen (A. Stacher, Hrsg.), S. 524. Wien: Bohmann 1969.Google Scholar
  390. Lille, L., Desplaces, A., Meeus, L., Saracino, R.T.: Thymus-derived proliferating lymphocytes in chronic lymphocytic leukaemia. Lancet 1973 II, 263.CrossRefGoogle Scholar
  391. Lindström, F.D., Hardy, W.R., Eberle, B.J., Williams, R.C. jr.: Multiple myeloma and benign monoclonal gammopathy: Differentiation by immunofluorescence of lymphocytes. Ann. intern. Med. 78, 837 (1973).PubMedGoogle Scholar
  392. Linke, A., Freudenberger 1966. Obrecht, P.: Die Lebenserwartung Hämoblastosekranker. Med. Klin. 61, 1985 (1966).Google Scholar
  393. Linke, A., Matthes, K.: In: Handbuch Inn. Medizin (H. Schwiegk, Hrsg.), Bd. IX/4: Herz und Kreislauf. Berlin-Heidelberg-Göttingen: Springer 1960.Google Scholar
  394. Lisker, S.A., Brody, J.D., Beizer, L.H.: Abnormal carbohydrate metabolism in patients with malignant blood dyscrasias. Amer. J. med. Sci. 252, 282 (1966).PubMedCrossRefGoogle Scholar
  395. Löffler, H.: Zytologische Diagnostik der malignen Lymphome. In: Leukämien und maligne Lymphome (A. Stacher, Hrsg.). München-Berlin-Wien: Urban & Schwarzenberg 1973.Google Scholar
  396. Löffler, H., Meyhöfer, W., Lange, R.H., Ehlers, G., Remmele, W.: Sezary-Syndrom, eine leukämische Variante der Mykosis fungoides. Dtsch. med. Wschr. 99, 429 (1974).PubMedCrossRefGoogle Scholar
  397. Löhr, G.W.: Stoffwechseleigenschaften und Enzyme der Leukozyten des Menschen. Folia haemat. (N.F.) 6, 49 (1961).Google Scholar
  398. Lockwood, K., Stancke, B., Clemmesen, J.: Survival rates for leukemia in various countries. Nat. Cancer Inst. Monogr. 15, 341 (1964).PubMedGoogle Scholar
  399. Lortholary, P., Boiron, M., Ripault, J., Levacher, A., Mielot, F., Bernard, J.: Trois observations de transformation aigue d’hemopathies lymphocytaires chroniques. Nouv. Rev. franç. Hémat. 6, 637 (1966).PubMedGoogle Scholar
  400. Lukes, R.J.: Malignant lymphoma-histologic considerations. Rec. Res. Cancer Res. 36, 6 (1971).Google Scholar
  401. Lukes, R.J., Craver, L.F., Hall, T.C., Rappaport, H., Rubin, P.: Report of the Nomenclature Committee. Cancer Res. 26, 1311 (1966).Google Scholar
  402. Lumb, G.: Tumours of Lymphoid Tissue. E.&S. Livingstone: Edinburgh & London 1954.Google Scholar
  403. Lynch, E.C.: Uric acid metabolism in proliverative diseases of the marrow. Arch, intern. Med. 109, 639 (1962).Google Scholar
  404. MacMahon, B., Clark, D.: Incidence of the common forms of human leukemia. Blood 11, 871 (1956).PubMedGoogle Scholar
  405. MacMahon, B., Koller, E.K.: Ethnic differences in the incidence of leukemia. Proc. 6th. Internat. Congr. Internat. Soc. Hematology. New York: Grune&Stratton 1958.Google Scholar
  406. Mähr, G., Königstein, R.P.: Die sog. medulläre Verlaufsform der chronischen leukämischen Lymphadenose. Wien. klin. Wschr. 72, 840 (1960).Google Scholar
  407. Manaster, J., Frühling, J., Stryckmans, P.: Kinetics of lymphocytes in chronic lymphocytic leukemia. I. Equilibrium between blood and a „readily accesible pool“. Blood 41, 425 (1973).PubMedGoogle Scholar
  408. Marchalonis, J.I., Cone, R.E.: Biochemical and biological characteristics of lymphocyte surface immunoglobulin. Transplant. Rev. 14, 3 (1973).PubMedGoogle Scholar
  409. Marlow, A.A., Bartlett, G.R.: Survival for twenty-nine years in chronic lymphocytic leukemia. J. Amer. med. Ass. 152, 1033 (1953).Google Scholar
  410. Marmont, A.M., Bordo, D., Damasio, E.E., Gori, G., Rossi, F.: Clinical experiences with Peptichemio in the treatment of hematologic malignancies. In: Leukämien und maligne Lymphome (A. Stacher, Hrsg.), S. 371. München-Berlin-Wien: Urban & Schwarzenberg 1973.Google Scholar
  411. Marmont, A.M., Damasio, E.E.: B lymphocytes in macroglobulinaemia. Lancet 1971 II, 1326.CrossRefGoogle Scholar
  412. Marsaglia, G., Thomas, E.D.: The radiation dose accumulated by blood during extracorporeal irradiation. Radiat. Res. 25, 269 (1965).PubMedCrossRefGoogle Scholar
  413. Marshall, R.A.: A review of lesions in the optic fundus in various diseases of the blood. Blood 14, 882 (1959).PubMedGoogle Scholar
  414. Martin, H., Fischer, M., Schubert, J.C.F.: Die Chemotherapie der chronischen Leukosen. In: Leukämie (R. Gross, J. v.d. Loo, Hrsg.), S. 515. Berlin-Heidelberg-New York: Springer 1972.Google Scholar
  415. Mathe, G., Schwarzenberg, L., Amiel, J.L.: Approches immunologiques du traitement des leucémies. Premiers resultats chez l’homme. Nouv. Rev. franç. Hémat. 7, 721 (1967).PubMedGoogle Scholar
  416. McCleland, D.A., Bridges, I.M.: The total N-acetyl neuraminic acid content of human normal and lymphatic leukaemic lymphocytes. Brit. J. Cancer 27, 114 (1973).CrossRefGoogle Scholar
  417. McCormick, D.P., Ammann, A.J., Ishizaka, K.: A study of allergy in patients with malignant lymphoma and chronic lymphocytic leukemia. Cancer 27, 93 (1971).PubMedCrossRefGoogle Scholar
  418. Mackenzie, M.R., Fudenberg, H.H.: Macroglobulinemia: An analysis for forty patients. Blood 39, 874 (1972).PubMedGoogle Scholar
  419. McLaughlin, H., Wetherly-Mein, G., Pitcher, C., Hobbs, J.R.: Non-immunoglobulin-bearing ‘B’ lymphocytes in chronic lymphatic leukaemia? Brit. J. Haemat. 25, 7 (1973).PubMedCrossRefGoogle Scholar
  420. McPhedran, P., Heath, C.W.: Acute leukemia occurring during chronic lymphocytic leukemia. Blood 35, 7 (1970).PubMedGoogle Scholar
  421. Meckstroth, C.V., Rapport, R.L., Curtis, G.M., Simeox, S.J.: The laboratory diagnosis of extrathyroidal hypermetabolism. J. clin. Endocrin. 12, 1373 (1952).CrossRefGoogle Scholar
  422. Merker, H.: Cytochemie der Blutzellen. In: Handbuch der inneren Medizin (L. Heilmeyer, H. Begemann, Hrsg.), Bd. II/I. Berlin-Heidelberg-New York: Springer 1968.Google Scholar
  423. Meuret, G., Fliedner, T.M., Schütz, W., Öhl, N., Afkham, J., Obrecht, P., Musshoff, K.: Erfahrungen mit der extrakorporalen Blutbestrahlung bei der Behandlung der chronisch lymphatischen Leukämie. Klin. Wschr. 49, 899 (1971).PubMedCrossRefGoogle Scholar
  424. Meuret, G., Schütz, W., Harris, E.B., Fliedner, T.M., Hoelzer, D., Afkham, J., Obrecht, P., Musshoff, K., Heinze, V., Tourkantonis, A.: Die Behandlung der chronisch-lymphatischen Leukämie durch extrakorporale Blutbestrahlung unter Verwendung konventioneller Strahlenthe-rapiegeräte. Strahlentherapie 137, 429 (1969).PubMedGoogle Scholar
  425. Mikulicz, J.v.: Über eine eigenartige symmetrische Erkrankung der Tränen- und Mundspeicheldrüsen. In: Chir. Festschrift f. Th. Billroth, S. 610. Stuttgart: 1892.Google Scholar
  426. Miller, D.G.: Patterns of immunological deficiency in lymphomas and leukemias. Ann. intern. Med. 57, 703 (1962).Google Scholar
  427. Miller, D.G., Budinger, J.M., Karnofsky, D.A.: A clinical and pathological study of resistance to infection in chronic lymphatic leukemia. Cancer 15, 307 (1962).PubMedCrossRefGoogle Scholar
  428. Miller, D.G., Diamond, H.G., Craver, L.F.: Critical study of clinical use of chlorambucil. New Engl. J. Med. 261, 525 (1959).PubMedCrossRefGoogle Scholar
  429. Miller, D.G., Karnofsky, D.A.: Immunologic factors and resistance to infection in chronic lymphatic leukemia. Amer. J. Med. 31, 748 (1961).PubMedCrossRefGoogle Scholar
  430. Miller, D.G., Lizardo, I.G., Snyderman, R.K.: Homologous and heterologous skin transplantation in patients with lymphomatous disease. J. nat. Cancer Inst. 26, 569 (1961).PubMedGoogle Scholar
  431. Minot, G.R., Buckman, T.E.: The blood platelets in the leukemias. Amer. J. med. Sci. 169, 477 (1925).CrossRefGoogle Scholar
  432. Minot, G.B., Isaacs, R.: Lymphatic leukemia; age incidence, duration and benefit derived from irradiation. Boston med. Surg. J. 191, 1 (1924).Google Scholar
  433. Mitchison, N.A.: The carrier effect in the secondary response to hapten-protein conjugates. II. cellular cooperation. Europ. J. Immunol. 1, 18 (1971).CrossRefGoogle Scholar
  434. Mitus, W.J., Bergna, L.I., Mednicoff, L.B., Dameshek, W.: Cytochemical studies of glycogen content of lymphocytes in lymphocytic proliferations. Blood 13, 748 (1958).PubMedGoogle Scholar
  435. Mlczoch, F., Kohout, J.: Das Gewebsbild bei malignen Erkrankungen. Untersuchungen mit der Hautfenstermethode an 124 Fällen. Klin. Wschr. 43, 627 (1965).PubMedCrossRefGoogle Scholar
  436. Modan, B., Lilienfeld, A.M.: Leukaemogenic effect of ionizing-irradiation treatment in polycythaemia. Lancet 1964 II, 439.CrossRefGoogle Scholar
  437. Moertel, C.G., Hagedorn, A.B.: Leukemia or lymphoma and coexistent primary malignant lesions: A review of the literature and a study of 120 cases. Blood 12, 788 (1957).PubMedGoogle Scholar
  438. Moeschlin, S.: Die pseudoaplastische Anämie. Schweiz, med. Wschr. 90, 1198 (1960).Google Scholar
  439. Moeschlin, S.: Zeitgemäße Behandlung der Leukosen. Schweiz, med. Wschr. 95, 221 (1965).Google Scholar
  440. Moeschlin, S.: Die heutige Anwendung von Zytostatika in Klinik und Praxis. Med. Klin. 60, 1185 (1965).PubMedGoogle Scholar
  441. Mohr, R.: Über Funktion von B- und T-Zellen. In: Lymphozyt und klinische Immunologie (H. Theml, H. Begemann, Hrsg.). Berlin-Heidelberg-New York: Springer 1975.Google Scholar
  442. Moloney, W.C.: Treatment of chronic leukemia. Proc. Internat. Conf. on Leukemia-Lymphoma, p. 447. Philadelphia: Lea&Febiger 1968.Google Scholar
  443. Moore, D.F., Mobliore, P.J., Schulenberger, C.C., Alexanian, R.: Monoclonal macroglobulinemai in malignant lymphoma. Ann. intern. Med. 72, 43 (1970).PubMedGoogle Scholar
  444. Moroz, C., Shalmon, L., Hahn, J.: Synthesis of surface immunoglobulin by lymphocyte leukemia cells in vitro. Europ. J. Immunol. 3, 16 (1973).CrossRefGoogle Scholar
  445. Moseley, J.E.: Patterns of bone change in the leukemias and myelosclerosis. J. Mt. Sinai Hosp. 28, 1 (1961).Google Scholar
  446. Müller, D., Ferger, W., Missmahl, H.P.: Entstehung und Bedeutung der Gumprecht’sehen Kernschatten bei chronisch lymphatischer Leukämie. Blut 21, 201 (1970).PubMedCrossRefGoogle Scholar
  447. Mueller-Eckhardt, Ch.: Thrombozytäre hämorrhagische Diathesen. In: Klinische Hämatologie (H. Begemann, Hrsg.), p. 730. Stuttgart: Thieme 1970.Google Scholar
  448. Murphy, J.B., Sturm, E.: Effect of adrenal corical and pituitary adrenotropic hormone on transplanted leukemia in rats. Science 99, 303 (1944).PubMedCrossRefGoogle Scholar
  449. Musshoff, K., Staib, I., Oehlert, W., Pauli-Beisel, Ch., Löhr, G.W., Slanina, J., Böttcher, D.: Primäre und sekundäre Laparotomie mit Splenektomie bei Patienten mit Morbus Hodgkin. Klin. Wschr. 52, 24 (1974).PubMedCrossRefGoogle Scholar
  450. Naegeli, O.: Dtsch. med. Wschr. 1900, 287.Google Scholar
  451. Najman, A., Sonsino, E., Buu Hoi, A.: La coloration par le PAS des lymphocytes dans la leucemie lymphoide chronique. Confrontation avec la culture de lymphocytes. Nouv. Rev. franç. Hémat. 9, 737 (1969).PubMedGoogle Scholar
  452. Navone, R., Mazzucco, G., Stramignoni, A.: Quantitative studies of macrophages in blood cultures in chronic lymphocytic leukaemia. Acta haemat. (Basel) 49, 335 (1973).CrossRefGoogle Scholar
  453. Neiman, P.E., Henry, P.H.: Ribonucleic acid desoxyribonucleic acid hybridization and hybridization competition studies of the rapidly labelled rivonucleic acid from normal and chronic lymphocytic leukemia lymphocytes. Biochemistry (Washington) 8, 275 (1968).CrossRefGoogle Scholar
  454. Nelson, J.K., Mackay, J.S., Sheridan, B., Weaver, J.A.: Intermittent therapy with corticotropin. Lancet 1966 II, 78.CrossRefGoogle Scholar
  455. Neumann, E.: Ein Fall von Leukämie mit Erkrankung des Knochenmarkes. Arch. Heilk. 11, 1 (1870).Google Scholar
  456. Neumann, E.: Über myelogene Leukämie. Berl. klin. Wschr. 15, 69 (1878).Google Scholar
  457. Noetzel, H.: Raumfordernde intracerebrale Metastase bei chronischer Lymphadenose. Beitr. path. Anat. 119, 114 (1958).Google Scholar
  458. Norman, A., Sasaki, M.S., Ottoman, R.E., Fingerhut, A.G.: Lymphocyte lifetime in women. Science 147, 745 (1965).PubMedCrossRefGoogle Scholar
  459. Norris, H.J., Wiener: The renal lesions in leukemia. Amer. J. med. Sci. 241, 512 (1961).PubMedCrossRefGoogle Scholar
  460. Nowell, P.C.: Differentiation of human leucemic leukocytes in tissue culture. Exp. Cell Res. 19, 267 (1960).PubMedCrossRefGoogle Scholar
  461. Obrecht, P.: Die Therapie der akuten und chronischen lymphatischen Leukämie. In: Handb. d. Ges. Haematologie (L. Heilmeyer, A. Hittmair, Hrsg.), Bd. IV/2, S. 506. München-Berlin-Wien: Urban & Schwarzenberg 1963.Google Scholar
  462. Obrecht, P.: Die Lebenserwartung Hämoblastosekranker. Med. Klin. 61, 1985 (1966).PubMedGoogle Scholar
  463. Obrecht, P.: Die Chemotherapie der Leukämien. Internist 9, 489 (1968).PubMedGoogle Scholar
  464. Obrecht, P., Heilmeyer, L.: Die Behandlung der chronischen lymphatischen Leukämie. Münch. med. Wschr. 108, 1717 (1966).PubMedGoogle Scholar
  465. Oppenheim, J.J., Wang, J., Frei, E.: Immunologie and cytogenetic studies of chronic lymphocytic leukemic cells. Blood 26, 121 (1965).PubMedGoogle Scholar
  466. Osgood, E.E.: Treatment of chronic leukemias. J. nucl. Med. 5, 139 (1964).PubMedGoogle Scholar
  467. Osgood, E.E.: The relative dosage required of total body X-ray Vs intravenous 32P for equal effectivenes against leukemic cells of the lymphocytic series or granulocytic series in chronic leukemia. Nucl.-Med. (Stuttg.) 6, 421 (1965).Google Scholar
  468. Osgood, E.E., Seaman, A.I.: Treatment of the chronic leukemias: results of therapy of 163 patients by titrated, regularly spaced total body radioactive phosphorus or roentgen irradiation. J. Amer. med. Ass. 150, 1372 (1952).Google Scholar
  469. Osgood, E.E., Tivey, H., Davison, K.B., Seaman, A.J., Li, J.G.: The relative rates of formation of new leukocytes in patients with acute and chronic leukemias. Cancer 5, 331 (1952).PubMedCrossRefGoogle Scholar
  470. Owen, J.J.T., Ritter, M.A.: Tissue interaction in the development of thymus lymphocytes. J. exp. Med. 129, 431 (1969).PubMedCrossRefGoogle Scholar
  471. Panton, P.N., Valentine, F.C.O.: Chronic lymphoid leukaemia. Lancet 1929 I, 914.CrossRefGoogle Scholar
  472. Pappas, A., Lennartz, K.J., Scheurlen, P.G., Freyberger, H.: Proliferationskinetik phytohämagglutininstimulierter Lymphozyten von Patienten mit chronischer Lymphadenose und Lymphogranulomatose. Med. Welt 22, 123 (1971).Google Scholar
  473. Papamichael, M., Brown, J.C., Holborouw, E.J.: Immunoglobulins on the surface of human lymphocytes. Lancet 1971 II, 850.CrossRefGoogle Scholar
  474. Parmentier, C., Schlienger, M., Hayat, M., Laugier, A., Schlumberger, J.R., Mathe, G., Tubiana, M.: L’irradiation splenique dans les leukemics lymphocytaires chroniques decompensees. J. Radiol. Électrol. 49, 187 (1968).PubMedGoogle Scholar
  475. Pascucci, L.M.: Chronic leukemia: A statistical study of symptoms, duration of life and prognosis. Radiology 39, 75 (1942).Google Scholar
  476. Patt, H.M.: Protective mechanisms in ionizing radiation injury. Physiol. Rev. 33, 35 (1953).PubMedGoogle Scholar
  477. Paulisch, R.: Therapie malignet Lymphome mit Trophosphamid. In: Leukämien und maligne Lymphome (A. Stacher, Hrsg.), S. 428. München-Berlin-Wien: Urban & Schwarzenberg 1973.Google Scholar
  478. Peacocke, J., Amos, B., Laszlo, J.: The defection of iso-antigens on leukemic celll using the cytotoxicity test. Blood 28, 665 (1966).PubMedGoogle Scholar
  479. Pearson, D.H., Eliel, L.P.: Use of pituitary adrenocorticotropic hormone (ACTH) and cortisone in Lymphomas and leukemias. J. Amer. med. Ass. 144, 1349 (1950).Google Scholar
  480. Pearson, D.H., Eliel, L.P., Rawson, R.W., Dobringer, K., Rhoads, C.P.: ACTH and corticone-induced regression of lymphoid tumors in man. Cancer 2, 945 (1949).Google Scholar
  481. Pearson, B., Stasney, J., Pizzolato, P.: Gastrointestinal involvement in lymphatic leukemia. Arch. Path. 35, 21 (1943).Google Scholar
  482. Pease, G.L., McDonald, J.R.: Lymphoblastomatous involvement of nonlymphoid organs. Amer. J. clin. Path. 17, 181 (1947).Google Scholar
  483. Perera, D.I.B., Pegrum, G.D.: The lymphocyte in chronic lymphatic leukemia. Lancet 1974 I, 1207.CrossRefGoogle Scholar
  484. Perkins, J., Israels, M.C.E., Wilkinson, J.F.: Polycythemia vera: Clinical studies on a series of 127 patients managed without radiation therapy. Quart. J. Med. 33, 499 (1964).PubMedGoogle Scholar
  485. Perlick, E.: Das Komplement- und Properdinsystem bei Hämoblastosen. Verh. dtsch. Ges. inn. Med. 66, 914 (1960).Google Scholar
  486. Perry, S.: Coagulation defects in leukemia. J. Lab. clin. Med. 50, 229 (1957).PubMedGoogle Scholar
  487. Perry, S.: Circulation lymphocytaire chez l’homme normal. Nouv. Rev. franç. Hémat. 8, 603 (1968).PubMedGoogle Scholar
  488. Peter, C.R., Mackenzie, M.R., Glassy, F.J.: T or B cell origin of some non-Hodgkin’s lymphomas. Lancet 1974 II, 686.CrossRefGoogle Scholar
  489. Peters, P.: Die endolymphatische Therapie mit 131J-Lipiodol. Kinetik, Indikation und Technik. Nucl.-Med. (Stuttg.) 10, 150 (1971).Google Scholar
  490. Peterson, R.D.A., Cooper, M.D., Good, R.A.: The pathogenesis of immunologic deficiency diseases. Amer. J. Med. 38, 579 (1965).PubMedCrossRefGoogle Scholar
  491. Pfisterer, H., Lani, K., Demmler, K., Thierfelder, S., Fateh-Moghadam, A., Land, W., Brendel, W., Stich, W.: Über die Wirkung von heterologem Antilymphozytenglobulin bei chronischer lymphatischer Leukämie. Dtsch. med. Wschr. 96, 1468 (1971).PubMedCrossRefGoogle Scholar
  492. Pfisterer, H., Nennhuber, J., Bolland, H., Stich, W.: Lymphozytenabbau nach in-vitro-Markie-rungmit Na2 51CrO4. II. Untersuchungen bei chronischer lymphatischer Leukämie. Klin. Wschr. 54, 1073–1076 (1967).CrossRefGoogle Scholar
  493. Piessens, W.F., Schur, P.H., Moloney, W.C., Wintrop, H.C.: Lymphocyte surface immunoglobulins. Distribution and frequency in lymphoproliferative diseases. New Engl. J. Med. 288, 176 (1973).PubMedCrossRefGoogle Scholar
  494. Pisciotta, A.V., Hirschboeck, J.S.: Therapeutic considerations in chronic lymphocytic leukemia. Arch, intern. Med. 99, 334 (1957).Google Scholar
  495. Pitney, W.R., Joske, R.A., MacKinnon, N.L.: Folic acid and other absorption tests in lymphosarcoma, chronic lymphocytic leukaemia, and some related conditions. J. clin. Path. 13, 440 (1960).PubMedCrossRefGoogle Scholar
  496. Platt, W.R.: Effects of radioactive phosphorus on normal tissues. Arch. Path. 43, 1 (1947).PubMedGoogle Scholar
  497. Plenderleith, L.H.: Hairy cell leukemia. Canad. med. Ass. J. 102, 1056 (1970).PubMedGoogle Scholar
  498. Praetorius, E.: Überlebenszeit und Leistungsfähigkeit bei chemotherapeutisch behandelten Hämo-blastosen. Dtsch. Arch. klin. Med. 209, 192 (1963).PubMedGoogle Scholar
  499. Preud’Homme, J.L., Seligmann, M.: Surface bound immunoglobulins as a cell marker in human lymphoproliferative diseases. Blood 40, 777 (1972 a).PubMedGoogle Scholar
  500. Preud’Homme, J.L., Seligmann, M.: Anti-human IgG activity of membrane bound monoclonal immunoglobulin M in lymphoproliferative disorders. Proc. nat. Acad. Sci. (Wash.) 69, 2132 (1972b).CrossRefGoogle Scholar
  501. Preussner, S., Bast, G., Lorenz, E.: Untersuchungen zur Erythrozytenüberlebenszeit bei hämoblastosen. Folia haemat. 85, 29 (1966).Google Scholar
  502. Pribilla, W.: Über die Lebensdauer der Leukocyten und Erythrocyten bei den Leukämien. Verh. dtsch. Ges. inn. Med. 66, 799 (1960).Google Scholar
  503. Prolla, J.C., Kirsner, J.B.: The gastrointestinal lesions and complications of the leukemias. Ann. intern. Med. 61, 1084 (1964).PubMedGoogle Scholar
  504. Quaglino, D., Cowling, D.C., Hayhoe, F.G.J.: Cytochemical and autoradiographic studies on normal leucaemic cells short-term tissue cultures. Brit. J. Haemat. 10, 417 (1964).PubMedCrossRefGoogle Scholar
  505. Quaglino, D., Hayhoe, F.G.J.: Observations of the periodic acid Schiff reaction in lymphoproliferative diseases. J. Path. Bact. 78, 521 (1959).PubMedCrossRefGoogle Scholar
  506. Quattrin, N., Bile, G., Dini, E., Venturo, V.: Crioglobulinemia e macroglobulinemie. Minerva med. 52, 3197 (1961).PubMedGoogle Scholar
  507. Rabellino, E., Grey, H.M.: Immunoglobulins on the surface of lymphocytes. III. Bursal origin of surface immunoglobulins on chicken, lymphocytes. J. Immunol. 106, 1418 (1971).PubMedGoogle Scholar
  508. Rai, K.R., Cronkite, E.P., Chanana, A.D., Levy, R.N., Pasternack, B.S.: Clinical staging of chronic lymphocytic leukemia. Blood 46, 219 (1975).PubMedGoogle Scholar
  509. Rappaport, H.: Atlas of tumor pathology. Sect. 3, Fasc. 8: Tumors of the hematopoetic system. Washington D.C., AFIP 1966.Google Scholar
  510. Rebuck, J.W.: Structure of the lymphocytic series of cells in relation to disease. In: The Lymphocyte and Lymphocytic Tissue (J.W. Rebuck, P.B. Hoeber, Eds.). New York: Harper 1960.Google Scholar
  511. Rehn, K., Hunstein, W., Schreiter, B., Uhl, N.: Immunglobulinbestimmung bei hämatologischen Systemerkrankungen. 77. Tagung Dtsch. Ges. Inn. Med. Wiesbaden 1971.Google Scholar
  512. Reinhard, E.H., Neely, Ch.L., Samples, D.M.: Radioactive phosphorus in the treatment of chronic leukemias: long-term results over a period of 15 years. Ann. intern. Med. 50, 942 (1959).PubMedGoogle Scholar
  513. Richards, F., Spurr, C., Pajak, T., Blake, D., Raben, M.: Thymic irradiation. An approach to chronic lymphocytic leukemia. Amer. J. Med. 57, 862 (1974).PubMedCrossRefGoogle Scholar
  514. Rieke, W.O., Caffrey, R.W., Everett, N.B.: Rates of proliferation and interrelationships of cells in the mesenteric lymph node of the rat. Blood 22, 674 (1963).PubMedGoogle Scholar
  515. Rigas, D., Osgood, E.E.: Amer. J. med. 19, 292 (1955). Zit. nach Harwerth et al. (1963).CrossRefGoogle Scholar
  516. Riis, P.: The cytology of inflammatory exsudate. Kopenhagen: Munksgaard 1959.Google Scholar
  517. Riva, G.: Das Serumeiweißbild. Bonn-Stuttgart: Huber 1957.Google Scholar
  518. Rowe, D.S., Hug, K., Forne, L., Pernis, B.: Immunoglobulin D as a lymphocyte receptor. J. exp. Med. 138, 965 (1973).PubMedCrossRefGoogle Scholar
  519. Rundles, R.W., Barton, W.B.: Triethylene melamine in the treatment neoplastic disease. Blood 7, 483 (1952).PubMedGoogle Scholar
  520. Rundles, W.: Chronic lymphocytic leukemia. In: Hematology (W.J. Williams, E. Beutler, A.J. Erslev, R.W. Rundles Eds.), p. 880. New York: McGraw-Hill 1972.Google Scholar
  521. Rundles, R.W., Coonrad, E.V., Willard, N.L.: Summary of results obtained with TEM. Ann. N.Y. Acad. Sci. 68, 926 (1958).PubMedCrossRefGoogle Scholar
  522. Salmon, S.E., Seligmann, M.: B-cell-neoplasia in man. Lancet 1974II, 1230.Google Scholar
  523. Sandberg, A.A., Cartwright, G.E., Wintrobe, M.M.: Studies on leukemia. I. Uric acid excretion. Blood 11, 154 (1956).PubMedGoogle Scholar
  524. Sasaki, S., Sucki, T.: Mobilization of lymphocytes from lymph nodes and spleen by polysaccharide polysulphate. Nature 216, 1013 (1967).PubMedCrossRefGoogle Scholar
  525. Sbarra, A.J., Shirley, W., Selvaraj, R.J., Ouchi, E., Rosenbaucm, E.: The role of the phagocyte capabilities of leukocytes from lymphoproliferative disorders. Cancer Res. 24, 1958 (1964).PubMedGoogle Scholar
  526. Scheiffarth, F., Götz, H.: Experimentelle Untersuchungen zur Frage sensibilisierender Nebenwirkungen von Tetracosactid. Arzneimittel-Forsch. 20, 381 (1970).Google Scholar
  527. Scheurlen, P.G., Pappas, A., Ludwig, T.: Stimulation der Blutlymphocyten durch Phytohämagglutinin bei chronischer Lymphadenose, Lymphosarkomatose und Lymphogranulomatose. Klin. Wschr. 46, 483 (1968).PubMedCrossRefGoogle Scholar
  528. Schick, P.: Lymphozytenkinetik bei lymphatischen Systemerkrankungen (chronische lymphatische Leukämie, Lymphogranulomatose). Verh. dtsch. Ges. inn. Med. 79, 154 (1973).PubMedGoogle Scholar
  529. Schick, P., Theml, H., Kaboth, W., Czempiel, H., Begemann, H., Fliedner, T.M., Mailli, B., Zellner, J., Bremer, K., Bock, O.: Einflüsse von extrakorporaler Blutbestrahlung und Milzbestrahlung auf in vitro markierte und autotransfundierte Blutlymphozyten von CLL-Patienten. In: Leukämien und maligne Lymphome (A. Stacher, Hrsg.). München-Berlin-Wien: Urban & Schwarzenberg 1972.Google Scholar
  530. Schiffer, L.M.: Kinetics of chronic lymphocytic leukemia. Ser. Haematol. 1, 3 (1968).Google Scholar
  531. Schiffer, L.M., Atkins, H.L., Chanana, A.D., Cronkite, E.P., Greenberg, M.L., Johnson, J.S., Robertson, J.S., Stryckmans, P.A.: Extracorporeal irradiation of the blood in humans: Effects upon erythrocyte survival. Blood 27, 831 (1966).PubMedGoogle Scholar
  532. Schlesinger, M.: Anti-theta antibodies for detecting thymusdependent lymphocytes in the immune response of mice to SRBC. Nature 226, 1254 (1970).PubMedCrossRefGoogle Scholar
  533. Schmidt, C.G.: Behandlung der Leukämien: Therapiewoche 17, 701 (1967).Google Scholar
  534. Schmidt, C.G.: Alkylierende Cytostatika. Internist 12, 119 (1971).PubMedGoogle Scholar
  535. Schmidt, C.G., Gallmeier, W.M.: Zur Enzymtherapie der Leukaemien. Dtsch. med. Wschr. 93, 2299 (1968).PubMedCrossRefGoogle Scholar
  536. Schnappauf, H., Joel, D.D., Chanana, A.D., Di Giacomo, R., Cronkite, E.P.: The influence of in vitro irradiation of blood in red cell survival after auto- and homo-transfusion of cells labelled with 59Fe or 51Cr. Radiat. Res. 19, 409 (1963).CrossRefGoogle Scholar
  537. Schnappauf, H., Schnappauf, U.: Drainage des Ductus thoracicus und Größe des,,leicht mobilisierbaren“Lymphozytenpools bei Kälbern, Schafen und Hunden. Blut 16, 209 (1968).PubMedCrossRefGoogle Scholar
  538. Schoen, H.D.: Strahlentherapie der chronischen Leukosen. In: Leukämie (R. Gross, J. v.d. Loo, Hrsg.), S. 595. Berlin-Heidelberg-New York: Springer 1972.Google Scholar
  539. Schoen, R., Heckner, F., Marsch, A.: Das vielseitige Erscheinungsbild der lymphatischen Leukämie. Dtsch. med. Wschr. 78, 515 (1953).PubMedCrossRefGoogle Scholar
  540. Schreier, K., Zöller, E., Thomas, K., Hart, W., Stöckle, V., Bergmann, E.: Untersuchungen zum Aminosäurestoffwechsel menschlicher Leukozyten. Klin. Wschr. 29, 568 (1961).CrossRefGoogle Scholar
  541. Schreiner, B.F., Wehr, W.H.: Cancer associated with leukemia. Amer. J. Cancer 21, 368 (1934).Google Scholar
  542. Schrek, R.: Prednisolone sensitivity and cytology of viable lymphocytes as tests for chronic lymphocytic leukemia. J. nat. Cancer Inst. 33, 837 (1964).PubMedGoogle Scholar
  543. Schrek, R.: Ultrastructure of blood lymphocytes from chronic lymphocytic and lymphosarcoma cell leukemia. J. nat. Cancer Inst. 48, 51 (1972).PubMedGoogle Scholar
  544. Schrek, R., Donnelly, W.J.: Differences between lymphocytes of leukemic and non-leukemic patients with respect to morphologic features, motility and sensitivity to guinea pig serum. Blood 18, 561 (1961).Google Scholar
  545. Schrek, R., Rabinowitz, Y.: Effects of phytohemagglutinin on rat and normal and leukemic human blood cells. Proc. Soc. exp. Biol. (N.Y.) 113, 191 (1963).Google Scholar
  546. Schrek, R., Stefani, S.: Radioresistence of phytohemaglutinin treated normal and leukemic lymphocytes. J. nat. Cancer Inst. 32, 507 (1964).PubMedGoogle Scholar
  547. Schröder, K.: Über die cytochemische Darstellung und das Verhalten der alpha-Naphtylacetat-Esterase in menschlichen Blutzellen. Diss. Freiburg i. Brsg. 1960.Google Scholar
  548. Schubothe, H.: Serologie und klinische Bedeutung der Autohämantikörper. Basel-New York: Karger 1958.Google Scholar
  549. Schubothe, H.: Autoantikörper und hämolytische Anämien. In: Immunhämatologie (R. Gross, Hrsg.), S. 109. Stuttgart-New York: Schattauer 1970.Google Scholar
  550. Schulz, F.H.: Das Fibrinogen. Leipzig: Thieme 1953.Google Scholar
  551. Schumacher, H.R., Ginns, D.A., Warren, W.J.: Fungus infection complicating leukemia. Amer. J. med. Sci. 247, 313 (1964).PubMedCrossRefGoogle Scholar
  552. Schumacher, H.R., Mangel, T.K., Davies, K.D.: A lymphocyte of chronic lymphatic leukemia. I. Electron microscopy onset. Cancer 26, 895 (1970).PubMedCrossRefGoogle Scholar
  553. Schwartz, D.L., Pierre, R.V., Scheerer, P.P., Reed, E.C., Linman, J.W.: Lymphosarcoma cell leukemia. Amer. J. Med. 38, 778 (1965).PubMedCrossRefGoogle Scholar
  554. Schweitzer, M., Melief, C.J.M., Ploem, J.E.: Chronic lymphocytic leukemia in five siblings. Scand. J. Haematol. 11, 97 (1973).PubMedCrossRefGoogle Scholar
  555. Schwiegk, H., Turba, F.: Künstliche radioaktive Isotope in Physiologie, Diagnostik und Therapie. Berlin-Göttingen-Heidelberg: Springer 1961.Google Scholar
  556. Scott, B.B.: Leukaemia. Chronic lymphatic leukaemia. Lancet 1957I, 1162.Google Scholar
  557. Sell, S., Gell, P.G.H.: Studies on rabbit lymphocytes in vitro. Stimulation of blast transformation with an antialotype serum. J. exp. Med. 122, 423 (1965).PubMedCrossRefGoogle Scholar
  558. Sellei, C., Hartai, F.: Zytostatische Therapie maligner Lymphome. In: Leukämien und maligne Lymphome (A. Stacher, Hrsg.), S. 388. München-Berlin-Wien: Urban & Schwarzenberg 1973.Google Scholar
  559. Seligmann, M., Preud-Homme, J.-L., Brouet, J.-C.: B and T cell markers in human proliferative blood diseases and primary immunodeficiencies, with special reference to membrane bound immunoglobulins. Tranplant. Rev. 16, 85 (1973).Google Scholar
  560. Seligmann, M., Preud’Homme, J.L., Brouet, J.C.: Studies on surface immunoglobulins and other lymphocyte membrane markers in various lymphoproliferative and immunodeficiency diseases. In: Advances in the Biosciences, vol. 12. London: Pergamon Press 1974.Google Scholar
  561. Senn, H.: Infektabwehr bei Hämoblastosen. Berlin-Heidelberg-New York: Springer 1972.Google Scholar
  562. Senn, N.: Case of splenomedullary leukemia successfully treated by the use of roentgen ray. Med. Rec. (N.Y.) 64, 281 (1903).Google Scholar
  563. Sezary, A., Bouvrain, Y.: Erythrodermie avec presence de cellules montrueuses dans le derme et le sang circulant. Bull. Soc. Franc. Derm. Syph. 45, 254 (1938).Google Scholar
  564. Sezary, A., Horowitz, A., Maschas, H.: Erythrodermie avec presence de cellules monstrueuses dans le derme et dans le sang circulant (second cas). Bull. Soc. franç. Derm. Syph. 45, 395 (1938).Google Scholar
  565. Sharman, C., Crossen, P.E., Fitzgerald, P.H.: Lymphocyte number and response to phytohaemag-glutinin in chronic lymphocytic leukaemia. Scand. J. Haemat. 3, 375 (1966).PubMedCrossRefGoogle Scholar
  566. Shaw, R.K., Boogs, D.R., Silberman, H.R., Frei, E.: III: A study of prednisone therapy in chronic lymphocytic leukemia. Blood 17, 182 (1961).Google Scholar
  567. Shaw, R.K., Szwed, C., Boggs, D.R., Fahey, J.L., Frei, E., Morrison, E., Utz, J.P.: Infection and immunity in chronic lymphocytic leukemia. Arch. intern. Med. 106, 467 (1960).Google Scholar
  568. Sharp, A.A., Callender, Sh.: Extracorporeal irradiation of the blood. A possible therapeutic measure. Lancet 1962I, 353.Google Scholar
  569. Sharp, A.A., Garret, J.V., Turner, L., Gilbert, C.W., Halnan, K.E., Easson, E.C., Nuttall, P.M.: Extracorporeal irradiation of the blood in leukaemic patients. Brit. J. Haemat. 16, 39 (1969).CrossRefGoogle Scholar
  570. Silberman, S., Schrek, R.: Surface immunoglobulins of lymphocytes in chronic lymphocytic leukemia and disseminated lymphosarcoma. Exp. molec. Path. 20, 33 (1974).PubMedCrossRefGoogle Scholar
  571. Silver, R.T.: The treatment of chronic lymphocytic leukemia. Sem. Hemat. 6, 344 (1969).Google Scholar
  572. Sheehan, W.W.: The relationship between lymphocytic leukemia and lymphomas. Rec. Res. Cancer Res. 36, 24 (1971).Google Scholar
  573. Shevach, E.M., Herberman, R., Frank, M.M., Green, I.: Receptors for complement and immunoglobulin on human leukemic cells and human lymphoblastoid cell lines. J. clin. Invest. 51, 1933 (1972).PubMedCrossRefGoogle Scholar
  574. Shimkin, M.B., Lucia, E.L., Oppermann, K.C., Mettier, S.: Lymphocytic leukemia: An analysis of frequency, distribution and mortality at the university of California Hospital. Ann. intern. Med. 39, 1254 (1953).PubMedGoogle Scholar
  575. Shohat, B., Gitter, S., Lavie, D.: Action of elactericin. A on human leukemic and normal lymphocytes. J. nat. Cancer Inst. 38, 1 (1967).PubMedGoogle Scholar
  576. Silverberg, J.H., Dameshek, W.: Use of triethylene melamine in treatment of leukemia and leukosarcoma. J. Amer. med. Ass. 148, 1015 (1952).Google Scholar
  577. Slatkin, D.N., Jansen, C.R., Cronkite, E.P., Robertson, J.S.: Extracorporeal irradiation of blood: calculations of the radiation dose. Radiat. Res. 19, 409 (1963).PubMedCrossRefGoogle Scholar
  578. Smith, J.L., Cowling, D.C., Barker, C.R.: Response of lymphocytes in chronic lymphocytic leukaemia to plant mitogens. Lancet 1971I, 229.Google Scholar
  579. Smith, M.A., Evans, J., Steel, C.M.: Age-related variation in proportion of circulating T cells. Lancet 1974II, 922.Google Scholar
  580. Southam, C.M., Burchenal, J.H.: Therapy of the chronic leukemias. In: Cancer (R.W. Raven, Ed.), vol. 6. London: Butterworth 1959.Google Scholar
  581. Spengler, G.A., Roulet, D.L.A., Ricci, C., Schnider, U., Schoop, W., Kappeler, R., Riva, G.: Paraproteinemic bei chronischer Lymphadenose. Schweiz. med. Wschr. 91, 984 (1961).Google Scholar
  582. Spivak, J.L., Perry, S.: Lymphocytic kinetics in chronic lymphocytic leukaemia. Brit. J. Haemat. 18, 511 (1970).PubMedCrossRefGoogle Scholar
  583. Stacher, A., Böhnel, J.: Über die Relation von lymphatischen Leukämien bzw. Reaktionen zu Malignomen. Wien klin. Wschr. 78, 633 (1966).Google Scholar
  584. Stacher, A., Höcker, P., Gobets, M.A.: Therapie chronischer Leukämien durch Leukophorese mittels eines Zellseparators. Verh. dtsch. Ges. inn. Med. 79, 527 (1973).PubMedGoogle Scholar
  585. Starzl, T.E., Porter, K.A., Iwasaki, Y., Marchioro, T.L., Kashiwagi, N.: The use of heterologous antilymphocyte globulin in human renal homotransplantation. In: Antilymphocytic Serum (G.E.W. Wolstenholme, Ed.). London 1967.Google Scholar
  586. Stefanini, M., Dameshek, W.: The Hemorrhagic Disorders, p. 192. New York: Grune & Stratton 1955.Google Scholar
  587. Stein, H., Kaiserling, E., Lennert, K.: Neue Gesichtspunkte zur Systematik maligner Lymphome auf dem Boden immunchemischer Analysen. In: Leukämien und maligne Lymphome (A. Stacher, Hrsg.). München-Berlin-Wien: Urban & Schwarzenberg 1973 a.Google Scholar
  588. Stein, H., Kaiserling, E., Lennert, K.: Evidence of B-cell-origin of reticulum cell sarcoma. Virch. Arch., Abt. A 364, 51 (1974).Google Scholar
  589. Stein, H., Kaiserling, E., Lennert, K., Parwaresch, M.R.: Makroglobulinbildende chronische lymphatische Leukämie ohne Makroglobulinämie. Klin. Wschr. 51, 389 (1973 b).PubMedCrossRefGoogle Scholar
  590. Stein, H., Kaiserling, E., Stein, G.: Surface markers on hairy cells. Boll. Ist. sieroter, milan. 53, Suppl., 305 (1974).PubMedGoogle Scholar
  591. Stein, L.: Chronic lymphatic leukaemia presenting as neoplasm of the cervix uteri. J. Obstet. Gynaec. Brit. Emp. 56, 107 (1949).PubMedCrossRefGoogle Scholar
  592. Steinkamp, R.C., Lawrence, J.H., Born, J.L.: Long term experiences with the use of P32 in the treatment of chronic lymphocytic leukemia. J. nucl. Med. 4, 92 (1963).PubMedGoogle Scholar
  593. Sternberg, C.: Über Leukosarkomatose. Wien. klin. Wschr. 21, 475 (1908).Google Scholar
  594. Stich, W., Langhammer, H.: Multiple karzinome und Leukämie. Münch. med. Wschr. 103, 502 (1961).Google Scholar
  595. Stites, T.B., Ultmann, J.E.: Spontaneous rupture of the splen in chronic lymphocytic leukemia. Cancer 19, 1587 (1966).PubMedCrossRefGoogle Scholar
  596. Stobbe, H.: Veränderungen am Magen-Darmkanal bei Leukosen. Med. Klin. 53, 497 (1958).Google Scholar
  597. Storb, R., Epstein, R.B., Buckner, C.D., Thomas, E.D.: Treatment of chronic lymphocytic leukemia by extracorporeal irradiation. Blood 31, 490 (1968).PubMedGoogle Scholar
  598. Storti, E.: Über einen Fall von lymphatischer Leukämie mit ausschließlicher Lokalisation im Knochenmark und über die Bedeutung der Sternalpunktion für die Diagnose dieser Krankheitsform. Dtsch. Arch. klin. Med. 180, 612 (1937).Google Scholar
  599. Storti, E., Pederzini, A.: Clinical significance of the leukocyte resistance. Acta med. scand. 154, 417 (1956).PubMedCrossRefGoogle Scholar
  600. Strickstrock, K.H., Weissleder, H., Pfannenstiel, P., Afkham, I.K., Hoffmann, G., Musshoff, K.: Indikation und vorläufige Ergebnisse der endolymphatischen Radio-Isotopen-Therapie bei malignen Erkrankungen des lymphatischen Systems. In: Maligne Lymphome, S. 197. München-Berlin-Wien: Urban & Schwarzenberg 1969.Google Scholar
  601. Strumia, M.M., Strumia, P.V., Bassert, D.: Splenectomy in leucemia. Hematological and clinical effects on 34 patients and review of 299 published cases. Cancer Res. 26, 519 (1966).PubMedGoogle Scholar
  602. Stryckmans, P.A., Channan, A.D., Cronkite, E.P., Greenberg, M.L., Schiffer, L.M.: Studies on lymphocytes. X. Influence of extracorporeal irradiation of the blood on lymphocytes in Cll: Apparent correlation with RNA turnover. Rad. Res. 37, 118 (1969).CrossRefGoogle Scholar
  603. Symmers, D.: Lymphoid diseases. Arch. Path. 45, 73 (1948).PubMedGoogle Scholar
  604. Talbott, J.H.: Gout and blood dyscrasias. Medicine 38, 173 (1959).PubMedGoogle Scholar
  605. Ternynck, T., Dighiero, G., Follezou, J., Binet, J.-L.: Comparison of normal and CLL-lympho-cyte surface Ig determinants using peroxidase-labeled antibodies. I. Detection and quantitation of light chain determinants. Blood 43, 789 (1974).PubMedGoogle Scholar
  606. Terz, J.J., Curutchet, H.P., Lawrence, W.: Analysis of the cell cinetics of human solid tumours. Cancer 28, 1100 (1971).PubMedCrossRefGoogle Scholar
  607. Teschendorf, W.: Röntgenbestrahlungen des ganzen Menschen bei Blutkrankheiten. Verh. dtsch. Ges. inn. Med. 1935, 324.Google Scholar
  608. Teschendorf, W.: Ganzkörper- und Abschnittsbestrahlung beim Menschen (Teleröntgentherapie, Telestrahlentherapie). In: Handbuch der Medizinischen Radiologie (L. Diethelm, O. Olsson, F. Strnad, H. Vieten, A. Zuppinger, Hrsg.), Bd. XVI/1, Allgemeine Strahlentherapeutische Methodik, S. 361. Berlin-Heidelberg-New York: Springer 1970.Google Scholar
  609. Theml, H.: Pathomechanismus der chronischen lymphatischen Leukämie. Med. Klin. 67, 1461 (1972).PubMedGoogle Scholar
  610. Theml, H.: Die Therapie der chronischen lymphatischen Leukämie. Verh. dtsch. Ges. inn. Med. 79, 323 (1973).PubMedGoogle Scholar
  611. Theml, H., Begemann, H.: Die Bedeutung kinetischer und immunologischer Daten für ein pathome-chanisches Verständnis und eine kritische Therapie von Lymphomen. In: Lymphozyt und klinische Immunologie (H. Theml, H. Begemann, Hrsg.). Berlin-Heidelberg-New York: Springer 1975.Google Scholar
  612. Theml, H., Begemann, H., Issels, R., Kaboth, W., Schick, P., Czempiel, H., Winnewisser M.: Beeinflussung der T-Zellaktivität bei chronischer Lymphadenose durch verschiedene Therapieformen. Haematologia 8, 43 (1975).Google Scholar
  613. Theml, H., Kaboth, W.: Die Behandlung von chronischen Leukämien. Münch. med. Wschr. 115, 843 (1973a).PubMedGoogle Scholar
  614. Theml, H., Love, R., Begemann, H.: Pathomechanism of chronic lymphocytic leukemia. Annual Review of Medicine 28, 131 (1977).PubMedCrossRefGoogle Scholar
  615. Theml, H., Schick, P., Kaboth, W., Begemann, H.: Veränderungen der PHA-Stimulierbarkeit von CLL-Lymphozyten unter extracorporaler Bestrahlung. In: Leukämien und maligne Lymphome (A. Stacher, Hrsg.), S. 308. München-Berlin-Wien: Urban & Schwarzenberg 1973.Google Scholar
  616. Theml, H., Schick, P., Trepel, F., Be Swanlee, Kaboth, W., Begemann, H., Fliedner, T.M.: Kontinuierliche 3H-Thymidininfusion bei CLL: I. Neubildung und Umsatz von Lymphozyten. In: Leukämie (R. Gross, J. v.d. Loo, Hrsg.), S. 181. Berlin-Heidelberg-New York: Springer 1972.Google Scholar
  617. Theml, H., Schick, P., Trepel, F., Heltzel, U., Kaboth, W., Fliedner, T.M., Begemann, H.: Kinetik der nichtlymphatischen Leukozyten bei chronischer lymphatischer Leukämie (Abstr.). Blut 28, 217(1974).Google Scholar
  618. Theml, H., Trepel, F., Rastetter, J., Begemann, H.: DNS- und RNS-Synthese in benignen und malignen Lymphomen. Klin. Wschr. 45, 608 (1967).CrossRefGoogle Scholar
  619. Theml, H., Trepel, F., Schick, P., Kaboth, W., Begemann, H.: Kinetics of lymphocytes in chronic lymphocytic leukemia: Studies using continuous 3H-thymidine infusion in two patients. Blood 42, 623 (1973 c).Google Scholar
  620. Thiel, E., Dörmer, P., Eulitz, M.: Quantitative 125J-Autoradiographie einzelner Zellen. Histochemistry 43, 33 (1975).PubMedCrossRefGoogle Scholar
  621. Thomas, E.D., Epstein, R.P., Eschbach, J.W. jr., Frager, D., Buckner, C.D., Marsaglia, G.: Treatment of leukemia by extracorporeal irradiation. New Engl. J. Med. 273, 6 (1965).PubMedCrossRefGoogle Scholar
  622. Thomas, J.H., Powell, D.E.B.: Blood disorders in the elderly. Bristol: Wright 1971.Google Scholar
  623. Thomson, A.E.R., Mehrishi, J.N.: Surface properties of normal human circulating small lymphocytes and lymphocytes in CLL. Europ. J. Cancer 5, 199 (1969).Google Scholar
  624. Thomson, A.E.R., Robinson, M.A.: Cytocidal action of colchicine on lymphocytes in chronic lymphocytic leukemia. Lancet 1967 II, 868.Google Scholar
  625. Tiso, R., Giangrande, A.: Dimostrazione citochimica della attivita enzimatica della fosfatasi alcalina in linfociti di un caso di linfoadenosi cronica. Haemat. lat. (Milano) 10, 283 (1967).Google Scholar
  626. Toghill, P.J., Green, S.: Factors influencing splenic pooling of erythrocytes in the myelo- and lympho-proliferative syndroms. Acta haemat. (Basel) 49, 215 (1973).CrossRefGoogle Scholar
  627. Tomonaga, M.M.: Leukemia in Nagasaki atomic bomb survivors from 1945 through 1959. Bull. Wld. Hlth. Org. 26, 619 (1962).Google Scholar
  628. Trepel, F.: Kinetik der Lymphozyten. Verh. dtsch. Ges. inn Med. 79, 105 (1973).PubMedGoogle Scholar
  629. Trepel, F.: Zeilproliferation in malignen Lymphomen. In: Leukämien und maligne Lymphome (A. Stacher, Hrsg.), S. 212. München-Berlin-Wien: Urban & Schwarzenberg 1973.Google Scholar
  630. Trepel, F.: Number and distribution of lymphocytes in man. A critical analysis. Klin. Wschr. 52, 511 (1974).PubMedCrossRefGoogle Scholar
  631. Trepel, F., Rastetter, J., Theml, H., Stockhausen, G.: Nucleinsäuresynthese und Zytostatikawir-kung in pathologischen Lymphknotenzellen. Med. Klin. 61, 618 (1966).PubMedGoogle Scholar
  632. Trepel, F., Theml, H., Schick, P., Schneble, G., Bremer, K., Fliedner, T.M., Begemann, H.: Kontinuierliche 3H-Thymidinfusion bei CLL: IL Proliferation der Lymphknotenzellen. In: Leukämie (R. Gross, J. van de Loo, Eds.), p. 187. Berlin-Heidelberg-New York: Springer 1972.Google Scholar
  633. Tsirimbas, A.D., Pichlmayr, R., Hornung, B., Pfisterer, H., Thierfelder, S., Brendel, W., Stich, W.: Therapeutische Wirkungen von heterologem Antihumanlymphozytenserum (AHLS) bei chronischer lymphatischer Leukämie. Klin. Wschr. 46, 583 (1968).PubMedCrossRefGoogle Scholar
  634. Tsirimbas, A.D., Wittmann, K., Dörmer, P.: Zellkinetik in Lymphdrüsen. I. Bestimmung der Desoxyribonucleinsäure — Synthesedauer bei Patienten mit 3H-Thymidin und 14-C-Thymidin in vivo. Klin. Wschr. 48, 923 (1970).PubMedCrossRefGoogle Scholar
  635. Turk, J.L., Poulter, L.W.: Selective depletion of lymphoid tissue by cyclophosphamide. Clin. exp. Immunol. 10, 285 (1972).PubMedGoogle Scholar
  636. Türk, W.: Ein System der Lymphomatosen. Wien. klin. Wschr. 16, 1073 (1903 a).Google Scholar
  637. Türk, W.: Offizielles Protokoll der k. k. Gesellschaft der Ärzte in Wien. Wien. klin. Wschr. 16, 1371 (1903b).Google Scholar
  638. Uehlinger, E.: Die Skelettveränderungen bei Leukämie. Fortschr. Röntgenstr. 77, 263 (1952).CrossRefGoogle Scholar
  639. Uhr, J.W., Scharff, M.: Delayed hypersensitivity. II. The effect of X-irradiation on the development of delayed hypersensitivity and antibody formation. J. exp. Med. 112, 65 (1960).PubMedCrossRefGoogle Scholar
  640. Ultmann, J.E., Fish, W., Osserman, E., Gellhorn, A.: The clinical implications of hypogammaglobulinemia in patients with chronic lymphocytic leukemia and lymphocytic lymphosarcoma. Ann. intern. Med. 51, 501 (1959).PubMedGoogle Scholar
  641. Unanue, E.R., Grey, H.M., Rabellino, E., Campbell, P., Schmidtke, J.: Immunoglobulins on the surface of lymphocytes. II. The bone marrow as the main source of lymphocytes with detectable surface-bound immunoglobulin. J. exp. Med. 133, 1168 (1971).CrossRefGoogle Scholar
  642. Uthgenannt, H.: Über Retikulopathien und das Phänomen der Pseudopolyposis lymphatica ilei. Fortschr. Röntgenstr. 90, 151 (1959).CrossRefGoogle Scholar
  643. Valentine, W.N.: The biochemistry and enzymatic activities of leucocytes in health and disease: In: Progress in Hematology (L.M. Tocantis, Ed.). New York: Grune & Stratton 1956.Google Scholar
  644. Videbaek, A.: Heridity in Human Leukemia and its Relation to Cancer. (Thesis). Copenhagen: Nyt Nordisk Forlag, Arnold Busck 1947.Google Scholar
  645. Videbaek, A.: Do malignant lymphomas represent varying differentiation of the same growth? Acta haemat. (Basel) 2, 201 (1949).Google Scholar
  646. Videbaek, A.: Haematologi. lsted. København: Munksgaard 1961.Google Scholar
  647. Videbaek, A.: On chronic lymphogenous leukaemia in association with pronounced splenomegaly. Proc. europ. Soc. Haemat. 2, 922 (1963).Google Scholar
  648. Vieta, J.O., Craver, L.F.: Intrathoracic manifestations of the lymphomatoid diseases. Radiology 37, 138 (1941).Google Scholar
  649. Viola, M.V., Dalton, A.J., Mitchell, E., Moloney, J.B.: Virus-like particles in a patient with chronic lymphocytic leukemia. New Engl. J. Med. 277, 503 (1967).PubMedCrossRefGoogle Scholar
  650. Virchow, R.: Weisses Blut. Neue Notizen aus dem Gebiete der Natur- und Heilkunde; gesammelt und mitgeteilt von L.F. v. Froriep u. R. Froriep 36, 151 (1845).Google Scholar
  651. Virchow, R.: Weisses Blut (Leukämie). Virchows Arch. path. Anat. 1, 563 (1847).Google Scholar
  652. Virchow, R.: Weisses Blut und Milztumoren. Med. Ztg. 16, 9, 15 (1847).Google Scholar
  653. Virchow, R.: Die krankhaften Geschwülste. Bd. 2, S. 567. Berlin: Hirschwald 1864/65.Google Scholar
  654. Vogt, A.: Die Behandlung der Leukämien mit Röntgenstrahlen. Strahlentherapie 77, 537 (1948).PubMedGoogle Scholar
  655. Voigt, K.-G., Helbig, W.: Pathologie und Klinik der leukämischen Niere. Med. Klin. 58, 867 (1963).PubMedGoogle Scholar
  656. Voigt, K.-G., Helbig, W.: Pathologie der Nieren bei Leukämien. Folia haemat. 81, 121 (1964).Google Scholar
  657. Wachstien, M.: Histochemical demonstration of reducing activity in normal and leukemic blood and bone marrow cells. Proc. Soc. exp. Biol. (N.Y.) 73, 306 (1950).Google Scholar
  658. Waagener, R., Pratt, P.T., Hunt, H.B.: Erythrocyte survival in leukemia, Hodgkin’s disease and malignant lymphoma as determined by radiochromate. Amer. J. Roentgenol. 79, 1045 (1958).Google Scholar
  659. Wagner, H.P., Eckmann, L.: Proliferative characteristics of thoracic duct lymphoid cells in man. Abstr. XIIIth Internat. Congr. Haemat. Munich 1970.Google Scholar
  660. Waisman, H.A.: Some Aspects of Amino Acid Metabolism in Leukemia. In: Henry Ford Hosp. Internat. Symposium: The Leukemias. New York: Academic Press 1957.Google Scholar
  661. Walford, R.L., Zeller, E., Combs, L., Konrad, P.: HL-A specificities in acute and chronic lymphatic leukemia. Transplant. Proc. 3, 1297 (1971).Google Scholar
  662. Ward, G.: The infective theory of acute leukaemia. Brit. J. Childr. Dis. 14, 10 (1917).Google Scholar
  663. Warnatz, H.: Tumorimmunologie. Stuttgart: Thieme 1975.Google Scholar
  664. Wasi, P., Block, M.: The mechanism of the development of anemia in untreated chronic lymphatic leukemia. Blood 17, 597 (1961).PubMedGoogle Scholar
  665. Wasserman, L.R., Stats, D., Schwartz, L., Fudenberg, H.: Symptomatic and hemopathic hemolytic anemia. Amer. J. Med. 18, 961 (1955).PubMedCrossRefGoogle Scholar
  666. Webster, L.T.: Lymphosarcoma. Lymphatic leukemia. Leucosarcoma. Hodgkin’s disease. Johns Hopkins Hosp. Resp. 20, 251 (1921).Google Scholar
  667. Weed, R.I.: Exaggerated delayed hypersensitivity to morquito bites in chronic lymphocytic leukemia. Blood 26, 257 (1969).Google Scholar
  668. Weisberger, A.S., Levine, B.: Incorporation of radioactive L-cytine by normal and leukemic leukocytes in vivo. Blood 9, 1082 (1954).PubMedGoogle Scholar
  669. Weisberger, A.S., Persky, L.: Renal calculi and ureamia as complications of lymphoma. Amer. J. med. Sci. 225, 669 (1953).PubMedCrossRefGoogle Scholar
  670. Weissleder, H., Baumeister, L.: Das lymphographische Bild der chronischen lymphatischen Leukämie. Fortschr. Röntgenstr. 105, 24 (1966).CrossRefGoogle Scholar
  671. Wells, R., Lau, K.S.: Incidence of leukaemia in Singapore, and rarity of chronic lymphocytic leukaemia in Chinese. Brit. med. J. 1960 I, 759.CrossRefGoogle Scholar
  672. Wernekke, G.: Lymphocytosis infectiosa. In: Handbuch der Inneren Medizin (H. Begemann, Hrsg.), Bd. II/5. Berlin-Heidelberg-New York: Springer 1974.Google Scholar
  673. West, H.F.: Effects of prolonged adrenocortical stimulation on patients with rheumatoid arthritis. Ann. rheum. Dis. 16, 322 (1957).PubMedCrossRefGoogle Scholar
  674. Westerhausen, M.: Immunglobulinveränderungen bei chronischer Lymphadenose. In: Der Lymphozyt. 1. Tagungsbericht der Österr. Ges. für Hämatologie (H. Pietschmann, Hrsg.), S. 171. Wien: Verlag Med. Akademie.Google Scholar
  675. Westerhausen, M.: Immundiffusionsuntersuchungen wasserlöslicher Antigene von Lymphocyten normaler Individuen und von Patienten mit chronischer lymphatischer Leukämie. Verh. dtsch. Ges. inn. Med. 74, 1271 (1968).PubMedGoogle Scholar
  676. Westerhausen, M.: Immunglobulinveränderungen und cytochemische Befunde bei der Beurteilung von chronischen lymphatischen Leukämien. In: Leukämie (R. Gross, J. van de Loo, Hrsg.). Berlin-Heidelberg-New York: Springer 1972a.Google Scholar
  677. Westerhausen, M.: Immunglobulinveränderungen bei der chronischen Lymphadenose (CLL). In: Leukämien und maligne Lymphome (A. Stacher, Hrsg.). München-Berlin-Wien: Urban & Schwarzenberg 1972 b.Google Scholar
  678. Wusterhausen, M.: Charakterisierung und Differenzierung der chronischen Lymphadenose nach klinischen, immunologischen und zytologischen Gesichtspunkten. Habilitationsschrift Freiburg (1972c).Google Scholar
  679. Wusterhausen, M.L., Oehlert, W.: Chronisches pluripotentielles immunproliferatives Syndrom. Dtsch. med. Wschr. 97, 1407 (1972).CrossRefGoogle Scholar
  680. Westring, D.W., Brittin, S.B.: The relative osmotic resistance of chronic lymphocytic leukemia lymphocytes. Blood 30, 674 (1967).PubMedGoogle Scholar
  681. Wetherley-Mein, G., Epstein, L.S., Foster, W.D., Grimes, A.J.: Mechanisms of anaemia in leukaemia. Brit. J. Haemat. 4, 281 (1958).PubMedCrossRefGoogle Scholar
  682. Whang-Peng, J., Gralnick, H.R., Johnson, R.E., Lee, E.C., Lear, A.: Chronic granulocytic leukemia (CGL) during the course of chronic lymphocytic leukemia (CLL): Correlation of blood, marrow, and spleen morphology and cytogenetics. Blood 43, 333 (1974).PubMedGoogle Scholar
  683. Whipham, T.: Splenic leukemia with carcinoma. Trans, path. Soc. Lond. 29, 313 (1878).Google Scholar
  684. Van de Wiele, R., Lieberman, S.: In: Biological activities of steroids in relation to cancer (G. Pincus, E.P. Vollmer, Eds.), p. 93. New York: Academic Press 1960.Google Scholar
  685. Wile, U.J., Holman, H.H.: Generalized herpes zoster associated with leukemia. Arch. Derm. Syph. 42, 587(1940).Google Scholar
  686. Wilmanns, W., Wilms, K., Rajewsky, M.F.: Biochemische Grundlagen der Behandlung von Leukosen. In: Leukämie (R. Gross, J. v.d. Loo, Hrsg.), S. 459. Berlin-Heidelberg-New York: Springer 1972.Google Scholar
  687. Will, J.J., Glazer, H.S., Vilter, R.W.: In: Henry Ford Hosp. Internat. Symposium: The Leukemias. New York: Academic Press 1957.Google Scholar
  688. Williams, H.M., Diamond, H.D., Lloyd, F.C.: The pathogenesis and management of neurological complications in patients with malignant lymphomas and leukemia. Cancer 11, 76 (1958).PubMedCrossRefGoogle Scholar
  689. Wilson, I.D., Hurdle, A.D.F.: Surface immunoblobulins on lymphocytes in chronic lymphocytic leukaemia and lymphosarcoma. Brit. J. Haemat. 24, 563 (1973).PubMedCrossRefGoogle Scholar
  690. Wilson, J.D., Nossal, G.J.V.: Identification of human T and B lymphocytes in normal peripheral blood and in chronic lymphocytic leukemia. Lancet 1971 II, 788.CrossRefGoogle Scholar
  691. Winkelmann, R.K., James, Ph.D., Linman, W.: Erythroderma with atypical lymphocytes (Sezary Syndrome). Amer. J. Med. 55, 192 (1973).PubMedCrossRefGoogle Scholar
  692. Wintrobe, M.M.: Clinical Hematology. 6th Ed. London: Kimpton 1967.Google Scholar
  693. Wintrobe, M.M., Mitchell, D.M.: Atypical manifestations of leukaemia. Quart. J. Med. 9, 67 (1940).Google Scholar
  694. Winzler, R.J.: Anticancer agents and nucleic acid metabolism of isolated human leukocytes. In: Henry Ford Hosp. Internat. Symposium: The Leukemias. New York: Academic Press 1957.Google Scholar
  695. Wiseman, B.K.: Lymphatic leukemia. J. Amer. med. Ass. 118, 100 (1942).Google Scholar
  696. Witts, L.J.: Recent work on leukaemia in man. Brit. med. J. 1957 I, 1197.CrossRefGoogle Scholar
  697. Wolstencroft, R.A., Mathew, M., Oates, C., Maini, R.M., Dumonde, D.C.: Lymphocyte mitogenic factor in cell-mediated immunity. In: The Role of Lymphocytes and Macrophages in the Immunological Response (D.C. Dumonde, Ed.). Berlin-Heidelberg-New York: Springer 1971.Google Scholar
  698. Wright, L.T., Wright, J.C., Prigot, A., Weintraub, S.: J. nat. med. Ass. (N.Y.) 42, 343 (1950).Google Scholar
  699. Wybran, I., Chantler, S., Fudenberg, H.H.: Isolation of normal T-cells in chronic lymphocytic leukemia. Lancet 1973 I, 126.CrossRefGoogle Scholar
  700. Yam, L.T., Li, C.Y., Finkel, H.E.: Leukemic reticuloendotheliosis. The role of tartrate-resistant acid phosphatase in diagnosis and splenectomy in treatment. Arch, intern. Med. 130, 248 (1972).CrossRefGoogle Scholar
  701. Yam, L.T., Li, C.Y., Lam, K.W.: Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis. N. Engl. J. Med. 284, 357 (1971).PubMedCrossRefGoogle Scholar
  702. Yoffey, J.M., Courtice, F.C.: Lymphatics, lymph and lymphoid tissue. London 1956.Google Scholar
  703. Yonet, H.M., Vigliano, E.M., Hofowitz, H.I.: Acute hemolytic anemia associated with administration of alkylating agents: report of two cases due to cyclophosphamide and review of the literature. Amer. J. med. Sci. 254, 70 (1967).CrossRefGoogle Scholar
  704. Zacharski, L.R., Linman, I.W.: Chronic lymphocytic leukemia versus chronic lymphosarcoma cell leukemia. Analysis of 496 cases. Amer. J. Med. 47, 75 (1969).PubMedCrossRefGoogle Scholar
  705. Zimmermann, T.S., Godwin, H.A., Perry, S.: Studies of leukocyte kinetics in chronic lymphocytic leukemia. Blood 31, 277 (1968).Google Scholar
  706. Zippin, C., Cutler, S.J., Reeves, W.J., Lum, D.: Survival in chronic lymphocytic leukemia. Blood 42, 367 (1973).PubMedGoogle Scholar
  707. Zlotnick, A., Robinson, E.: Chronic lymphatic leukemia associated with macroglobulinemia. Israel J. med. Sci. 6, 365 (1970).Google Scholar
  708. zum Winkel, K., Becker, J., Jahns, E., Scheurlen, H., Herzfeld, U.: Indikationsstellung und Dosimetrie bei der endolymphatischen Therapie mit 131J-Lipiodol. Strahlentherapie 133, 481 (1967).PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1978

Authors and Affiliations

  • Harald Theml

There are no affiliations available

Personalised recommendations